Procurement of Drugs and Medicine (EPA) IB NO. 2021-007...Infrastructure Projects, and/or Consulting Services required by the Procuring Entity. (2016 revised IRR, Section 5[e]) BIR

0

PHILIPPINE BIDDING DOCUMENTS

Procurement of

Drugs and Medicine

(EPA) IB NO. 2021-007

Government of the Republic of the Philippines

Sixth Edition

July 2020

1

Preface

These Philippine Bidding Documents (PBDs) for the procurement of Goods through

Competitive Bidding have been prepared by the Government of the Philippines for use by any

branch, constitutional commission or office, agency, department, bureau, office, or

instrumentality of the Government of the Philippines, National Government Agencies,

including Government-Owned and/or Controlled Corporations, Government Financing

Institutions, State Universities and Colleges, and Local Government Unit. The procedures and

practices presented in this document have been developed through broad experience, and are

for mandatory use in projects that are financed in whole or in part by the Government of the

Philippines or any foreign government/foreign or international financing institution in

accordance with the provisions of the 2016 revised Implementing Rules and Regulations of

Republic Act No. 9184.

The Bidding Documents shall clearly and adequately define, among others: (i) the

objectives, scope, and expected outputs and/or results of the proposed contract or Framework

Agreement, as the case may be; (ii) the eligibility requirements of Bidders; (iii) the expected

contract or Framework Agreement duration, the estimated quantity in the case of procurement

of goods, delivery schedule and/or time frame; and (iv) the obligations, duties, and/or functions

of the winning bidder.

Care should be taken to check the relevance of the provisions of the PBDs against the

requirements of the specific Goods to be procured. If duplication of a subject is inevitable in

other sections of the document prepared by the Procuring Entity, care must be exercised to

avoid contradictions between clauses dealing with the same matter.

Moreover, each section is prepared with notes intended only as information for the

Procuring Entity or the person drafting the Bidding Documents. They shall not be included in

the final documents. The following general directions should be observed when using the

documents:

a. All the documents listed in the Table of Contents are normally required for the

procurement of Goods. However, they should be adapted as necessary to the

circumstances of the particular Procurement Project.

b. Specific details, such as the “name of the Procuring Entity” and “address for

bid submission,” should be furnished in the Instructions to Bidders, Bid Data

Sheet, and Special Conditions of Contract. The final documents should contain

neither blank spaces nor options.

c. This Preface and the footnotes or notes in italics included in the Invitation to

Bid, Bid Data Sheet, General Conditions of Contract, Special Conditions of

Contract, Schedule of Requirements, and Specifications are not part of the text

of the final document, although they contain instructions that the Procuring

Entity should strictly follow.

2

d. The cover should be modified as required to identify the Bidding Documents as

to the Procurement Project, Project Identification Number, and Procuring

Entity, in addition to the date of issue.

e. Modifications for specific Procurement Project details should be provided in the

Special Conditions of Contract as amendments to the Conditions of Contract.

For easy completion, whenever reference has to be made to specific clauses in

the Bid Data Sheet or Special Conditions of Contract, these terms shall be

printed in bold typeface on Sections I (Instructions to Bidders) and III (General

Conditions of Contract), respectively.

f. For guidelines on the use of Bidding Forms and the procurement of Foreign-

Assisted Projects, these will be covered by a separate issuance of the

Government Procurement Policy Board.

3

Table of Contents

Glossary of Acronyms, Terms, and Abbreviations ………………………….4

Section I. Invitation to Bid……………………………………………………..7

Section II. Instructions to Bidders…………………………………………...11

1. Scope of Bid ………………………………………………………………………. 12

2. Funding Information………………………………………………………………. 12

3. Bidding Requirements ……………………………………………………………. 12

4. Corrupt, Fraudulent, Collusive, and Coercive Practices 13

5. Eligible Bidders…………………………………………………………………… 13

6. Origin of Goods ………………………………………………………………….. 14

7. Subcontracts ……………………………………………………………………… 14

8. Pre-Bid Conference ………………………………………………………………. 15

9. Clarification and Amendment of Bidding Documents …………………………… 15

10. Documents comprising the Bid: Eligibility and Technical Components …………. 15

11. Documents comprising the Bid: Financial Component …………………………... 16

12. Bid Prices …………………………………………………………………………. 16

13. Bid and Payment Currencies ……………………………………………………… 17

14. Bid Security ………………………………………………………………………. 17

15. Sealing and Marking of Bids ………………………………………………………18

16. Deadline for Submission of Bids …………………………………………………. 18

17. Opening and Preliminary Examination of Bids ………………………………….. 18

18. Domestic Preference ……………………………………………………………… 19

19. Detailed Evaluation and Comparison of Bids ……………………………………. 19

20. Post-Qualification ………………………………………………………………… 20

21. Signing of the Contract …………………………………………………………… 20

Section III. Bid Data Sheet …………………………………………………..22

Section IV. General Conditions of Contract ……………………...………..24 1. Scope of Contract ………………………………………………………………… 25

2. Advance Payment and Terms of Payment ……………………………………….. 25

3. Performance Security ……………………………………………………………. 25

4. Inspection and Tests ……………………………………………………………… 26

5. Warranty …………………………………………………………………………. 26

6. Liability of the Supplier ………………………………………………………….. 26

Section V. Special Conditions of Contract ………………………………….27

Section VI. Schedule of Requirements ……………………………………....32

Section VII. Technical Specifications …………………………………………34

Section VIII. Checklist of Technical and Financial Documents …………..38

4

Glossary of Acronyms, Terms, and

Abbreviations

ABC – Approved Budget for the Contract.

BAC – Bids and Awards Committee.

Bid – A signed offer or proposal to undertake a contract submitted by a bidder in response to

and in consonance with the requirements of the bidding documents. Also referred to as

Proposal and Tender. (2016 revised IRR, Section 5[c])

Bidder – Refers to a contractor, manufacturer, supplier, distributor and/or consultant who

submits a bid in response to the requirements of the Bidding Documents. (2016 revised IRR,

Section 5[d])

Bidding Documents – The documents issued by the Procuring Entity as the bases for bids,

furnishing all information necessary for a prospective bidder to prepare a bid for the Goods,

Infrastructure Projects, and/or Consulting Services required by the Procuring Entity. (2016

revised IRR, Section 5[e])

BIR – Bureau of Internal Revenue.

BSP – Bangko Sentral ng Pilipinas.

Consulting Services – Refer to services for Infrastructure Projects and other types of projects

or activities of the GOP requiring adequate external technical and professional expertise that

are beyond the capability and/or capacity of the GOP to undertake such as, but not limited to:

(i) advisory and review services; (ii) pre-investment or feasibility studies; (iii) design; (iv)

construction supervision; (v) management and related services; and (vi) other technical services

or special studies. (2016 revised IRR, Section 5[i])

CDA - Cooperative Development Authority.

Contract – Refers to the agreement entered into between the Procuring Entity and the Supplier

or Manufacturer or Distributor or Service Provider for procurement of Goods and Services;

Contractor for Procurement of Infrastructure Projects; or Consultant or Consulting Firm for

Procurement of Consulting Services; as the case may be, as recorded in the Contract Form

signed by the parties, including all attachments and appendices thereto and all documents

incorporated by reference therein.

CIF – Cost Insurance and Freight.

CIP – Carriage and Insurance Paid.

CPI – Consumer Price Index.

DDP – Refers to the quoted price of the Goods, which means “delivered duty paid.”

5

DTI – Department of Trade and Industry.

EXW – Ex works.

FCA – “Free Carrier” shipping point.

FOB – “Free on Board” shipping point.

Foreign-funded Procurement or Foreign-Assisted Project– Refers to procurement whose

funding source is from a foreign government, foreign or international financing institution as

specified in the Treaty or International or Executive Agreement. (2016 revised IRR, Section

5[b]).

Framework Agreement – Refers to a written agreement between a procuring entity and a

supplier or service provider that identifies the terms and conditions, under which specific

purchases, otherwise known as “Call-Offs,” are made for the duration of the agreement. It is in

the nature of an option contract between the procuring entity and the bidder(s) granting the

procuring entity the option to either place an order for any of the goods or services identified

in the Framework Agreement List or not buy at all, within a minimum period of one (1) year

to a maximum period of three (3) years. (GPPB Resolution No. 27-2019)

GFI – Government Financial Institution.

GOCC – Government-owned and/or –controlled corporation.

Goods – Refer to all items, supplies, materials and general support services, except Consulting

Services and Infrastructure Projects, which may be needed in the transaction of public

businesses or in the pursuit of any government undertaking, project or activity, whether in the

nature of equipment, furniture, stationery, materials for construction, or personal property of

any kind, including non-personal or contractual services such as the repair and maintenance of

equipment and furniture, as well as trucking, hauling, janitorial, security, and related or

analogous services, as well as procurement of materials and supplies provided by the Procuring

Entity for such services. The term “related” or “analogous services” shall include, but is not

limited to, lease or purchase of office space, media advertisements, health maintenance

services, and other services essential to the operation of the Procuring Entity. (2016 revised

IRR, Section 5[r])

GOP – Government of the Philippines.

GPPB – Government Procurement Policy Board.

INCOTERMS – International Commercial Terms.

Infrastructure Projects – Include the construction, improvement, rehabilitation, demolition,

repair, restoration or maintenance of roads and bridges, railways, airports, seaports,

communication facilities, civil works components of information technology projects,

irrigation, flood control and drainage, water supply, sanitation, sewerage and solid waste

management systems, shore protection, energy/power and electrification facilities, national

6

buildings, school buildings, hospital buildings, and other related construction projects of the

government. Also referred to as civil works or works. (2016 revised IRR, Section 5[u])

LGUs – Local Government Units.

NFCC – Net Financial Contracting Capacity.

NGA – National Government Agency.

PhilGEPS - Philippine Government Electronic Procurement System.

Procurement Project – refers to a specific or identified procurement covering goods,

infrastructure project or consulting services. A Procurement Project shall be described,

detailed, and scheduled in the Project Procurement Management Plan prepared by the agency

which shall be consolidated in the procuring entity's Annual Procurement Plan. (GPPB Circular

No. 06-2019 dated 17 July 2019)

PSA – Philippine Statistics Authority.

SEC – Securities and Exchange Commission.

SLCC – Single Largest Completed Contract.

Supplier – refers to a citizen, or any corporate body or commercial company duly organized

and registered under the laws where it is established, habitually established in business and

engaged in the manufacture or sale of the merchandise or performance of the general services

covered by his bid. (Item 3.8 of GPPB Resolution No. 13-2019, dated 23 May 2019). Supplier

as used in these Bidding Documents may likewise refer to a distributor, manufacturer,

contractor, or consultant.

UN – United Nations.

7

Section I. Invitation to Bid

Notes on the Invitation to Bid

The Invitation to Bid (IB) provides information that enables potential Bidders to decide

whether to participate in the procurement at hand. The IB shall be posted in accordance with

Section 21.2 of the 2016 revised IRR of RA No. 9184.

Apart from the essential items listed in the Bidding Documents, the IB should also indicate

the following:

a. The date of availability of the Bidding Documents, which shall be from the time the

IB is first advertised/posted until the deadline for the submission and receipt of bids;

b. The place where the Bidding Documents may be acquired or the website where it

may be downloaded;

c. The deadline for the submission and receipt of bids; and

d. Any important bid evaluation criteria (e.g., the application of a margin of preference

in bid evaluation).

The IB should be incorporated in the Bidding Documents. The information contained in the

IB must conform to the Bidding Documents and in particular to the relevant information in

the Bid Data Sheet.

8

Republic of the Philippines Department of Health

‘AMANG’ RODRIGUEZ MEMORIAL MEDICAL CENTER Sumulong Highway, Sto. Niño, Marikina City, Philippines 1800

Email Address: [email protected] / Website: www.armmc.doh.gov.ph Tel. Nos. (+632) 941-5854 & (+632) 948-1263

“PHIC Accredited”

INVITATION TO BID FOR THE PROCUREMENT OF DRUGS AND MEDICINE

Early Procurement Activity (EPA)

1. The Amang Rodriguez Memorial Medical Center, through the National Expenditure

for CY 2021 intends to apply the sum of Thirty Million Eight Hundred Fifty Two

Thousand Seven Hundred Seventy-Two Pesos and 04/100 Only (PhP30,852,772.04) being the ABC to payments under the contract for Drugs and Medicine, with IB N0.

2021-007. Bids received in excess of the ABC shall be automatically rejected at bid

opening.

2. The Amang Rodriguez Memorial Medical Center now invites bids for the above

Procurement Project. Delivery of the Goods is required by seven (7) calendar days

upon receipt of the Notice to Proceed. Bidders should have completed, within two (2)

years from the date of submission and receipt of bids, a contract similar to the Project.

The description of an eligible bidder is contained in the Bidding Documents,

particularly, in Section II (Instructions to Bidders).

3. Bidding will be conducted through open competitive bidding procedures using a non-

discretionary “pass/fail” criterion as specified in the 2016 revised Implementing Rules

and Regulations (IRR) of Republic Act (RA) No. 9184.

Bidding is restricted to Filipino citizens/sole proprietorships, partnerships, or

organizations with at least sixty percent (60%) interest or outstanding capital stock

belonging to citizens of the Philippines, and to citizens or organizations of a country

the laws or regulations of which grant similar rights or privileges to Filipino citizens,

pursuant to RA No. 5183.

4. Prospective Bidders may obtain further information from ARMMC BAC-Secretariat

and inspect the Bidding Documents at the address given below during 8:00am –

5:00pm.

5. A complete set of Bidding Documents may be acquired by interested Bidders on

November 25, 2020 from the given address and website(s) below and upon payment of

the applicable fee for the Bidding Documents, pursuant to the latest Guidelines issued

by the GPPB, in the amount of stated hereunder. The Procuring Entity shall allow the

bidder to present its proof of payment for the fees in person, or through e-mail.

mailto:[email protected]

http://www.armmc.doh.gov.ph/

9

PARTICULAR ABC

(PhP)

AMOUNT OF BID

DOCUMENTS

Group1-ANESTHESIAPREPARATION 2,418,049.20 5,000.00

Group 2- CONTRAST MEDIA 663,124.00 1,000.00

Group 3- CHEMOTHERAPY DRUGS 494,621.25 500.00

Group 4- GLUCOSE/ ELECTROLYTES/ IV FLUIDS 1,719,264.00 5,000.00

Group 5- EENT/ OPHTHA PREPARATIONS 185,436.30 500.00

Group 6- PARENTERAL SOLUTION 644,000.00 1,000.00

Group 7- PSYCHIATRY DRUGS 37,999.50 500.00

Group 8- SERA AND IMMUNOGLOBULINS 5,940,540.00 10,000.00

Group 9- VARIOUS DRUGS AND MEDICINE 16,974,737.79 25,000.00

Group 10- VOLUME EXPANDER 1,775.000.00 5,000.00

Total 30,852,772.04

6. The ARMMC Bids and Awards Committee (BAC) will hold a Virtual Pre-Bid

Conference on December 4, 2020, 3:00 pm which shall be open to prospective

bidders. Only one (1) authorized representative shall be allowed to attend. Link will

be sent thru email upon submission at the [email protected] of a letter

of intent to join the video conference not later than twenty four (24) hours before the

scheduled time.

7. Bids must be duly received by the BAC Secretariat through manual submission at the

office address indicated below on December 15, 2020 from 8:00 am to 12:00 noon at

the BAC Office, G/F, Payward Building. Late bids shall not be accepted.

8. All Bids must be accompanied by a bid security in any of the acceptable forms and in

the amount stated in ITB Clause 14.

9. Virtual Bid Opening shall be on December 16, 2020, 9:00 am via Zoom/Webex

Applications. Bids will be opened in the presence of the bidders’ representatives who

choose to attend the activity. Link will be sent thru email upon submission at the

[email protected] of proper identification (ID), email address, contact

number and an authorization letter from the Company that is being represented one day

prior to the scheduled bid opening.

10. Further, please refer to the attached Internal Guidelines on Procurement during

State of Calamity, Implementation of Community Quarantine or Similar

Restrictions.

11. The Amang Rodriguez Memorial Medical Center reserves the right to reject any and

all bids, declare a failure of bidding, or not award the contract at any time prior to

contract award in accordance with Sections 35.6 and 41 of the 2016 revised IRR of

RA No. 9184, without thereby incurring any liability to the affected bidder or bidders.

12. For further information, please refer to:

MARGARITA A. CHICO/JOSELINE E. PAGUIRIGAN, RN, MAN/

MENCHU T. ZINGAPAN, RN, MAN

BAC Secretariat

Procurement Office, G/F Administrative Building



10

[email protected]

948-1263 local 276

13. You may visit the following websites:

For downloading of Bidding Documents: www.armmc.doh.gov.ph /

www.philgeps.gov.ph

November 25, 2020

______________________________________

CLEOTILDE D.G. MALICSE, MD, FPPS, DIH

Chairperson

11

Section II. Instructions to Bidders

Notes on the Instructions to Bidders

This Section on the Instruction to Bidders (ITB) provides the information necessary for

bidders to prepare responsive bids, in accordance with the requirements of the Procuring

Entity. It also provides information on bid submission, eligibility check, opening and

evaluation of bids, post-qualification, and on the award of contract.

12

1. Scope of Bid

The Procuring Entity, AMANG RODRIGUEZ MEMORIAL MEDICAL CENTER

wishes to receive Bids for the Procurement of Drugs and Medicine, with identification

number 2021 - 007.

[Note: The Project Identification Number is assigned by the Procuring Entity based on

its own coding scheme and is not the same as the PhilGEPS reference number, which

is generated after the posting of the bid opportunity on the PhilGEPS website.]

The Procurement Project (referred to herein as “Project”) is composed of [indicate

number of lots or items], the details of which are described in Section VII (Technical

Specifications).

2. Funding Information

2.1. The GOP through the source of funding as indicated below for CY 2021 in the

amount of Thirty Million Eight Hundred Fifty-Two Thousand Seven Hundred

Seventy-Two Pesos & 04/100 Only (PhP30,852,772.04).

2.2. The source of funding is:

[If an early procurement activity, select one and delete others:]

a. NGA, the National Expenditure Program.

b. GOCC and GFIs, the proposed Corporate Operating Budget.

c. LGUs, the proposed Local Expenditure Program.

[If not an early procurement activity, select one and delete others:]

a. NGA, the General Appropriations Act or Special Appropriations.

b. GOCC and GFIs, the Corporate Operating Budget.

c. LGUs, the Annual or Supplemental Budget, as approved by the Sanggunian.

3. Bidding Requirements

The Bidding for the Project shall be governed by all the provisions of RA No. 9184 and

its 2016 revised IRR, including its Generic Procurement Manuals and associated

policies, rules and regulations as the primary source thereof, while the herein clauses

shall serve as the secondary source thereof.

Any amendments made to the IRR and other GPPB issuances shall be applicable only

to the ongoing posting, advertisement, or IB by the BAC through the issuance of a

supplemental or bid bulletin.

13

The Bidder, by the act of submitting its Bid, shall be deemed to have verified and

accepted the general requirements of this Project, including other factors that may affect

the cost, duration and execution or implementation of the contract, project, or work and

examine all instructions, forms, terms, and project requirements in the Bidding

Documents.

4. Corrupt, Fraudulent, Collusive, and Coercive Practices

The Procuring Entity, as well as the Bidders and Suppliers, shall observe the highest

standard of ethics during the procurement and execution of the contract. They or

through an agent shall not engage in corrupt, fraudulent, collusive, coercive, and

obstructive practices defined under Annex “I” of the 2016 revised IRR of RA No. 9184

or other integrity violations in competing for the Project.

5. Eligible Bidders

5.1. Only Bids of Bidders found to be legally, technically, and financially capable

will be evaluated.

5.2. [Select one, delete other/s]

a. Foreign ownership exceeding those allowed under the rules may participate

pursuant to:

i. When a Treaty or International or Executive Agreement as

provided in Section 4 of the RA No. 9184 and its 2016 revised IRR

allow foreign bidders to participate;

ii. Citizens, corporations, or associations of a country, included in the

list issued by the GPPB, the laws or regulations of which grant

reciprocal rights or privileges to citizens, corporations, or

associations of the Philippines;

iii. When the Goods sought to be procured are not available from local

suppliers; or

iv. When there is a need to prevent situations that defeat competition

or restrain trade.

b. Foreign ownership limited to those allowed under the rules may participate

in this Project.

5.3. Pursuant to Section 23.4.1.3 of the 2016 revised IRR of RA No.9184, the Bidder

shall have an SLCC that is at least one (1) contract similar to the Project the

value of which, adjusted to current prices using the PSA’s CPI, must be at least

equivalent to:

14

[Select one, delete the other/s]

a. For the procurement of Non-expendable Supplies and Services: The Bidder

must have completed a single contract that is similar to this Project,

equivalent to at least fifty percent (50%) of the ABC.

b. For the procurement of Expendable Supplies: The Bidder must have

completed a single contract that is similar to this Project, equivalent to

at least twenty-five percent (25%) of the ABC.

c. For procurement where the Procuring Entity has determined, after the

conduct of market research, that imposition of either (a) or (b) will likely

result to failure of bidding or monopoly that will defeat the purpose of

public bidding: the Bidder should comply with the following requirements:

[Select either failure or monopoly of bidding based on market research

conducted]

i. Completed at least two (2) similar contracts, the aggregate amount

of which should be equivalent to at least fifty percent (50%) in the

case of non-expendable supplies and services or twenty-five percent

(25%) in the case of expendable supplies] of the ABC for this

Project; and

ii. The largest of these similar contracts must be equivalent to at least

half of the percentage of the ABC as required above.

5.4. The Bidders shall comply with the eligibility criteria under Section 23.4.1 of the

2016 IRR of RA No. 9184.

6. Origin of Goods

There is no restriction on the origin of goods other than those prohibited by a decision

of the UN Security Council taken under Chapter VII of the Charter of the UN, subject

to Domestic Preference requirements under ITB Clause 18.

7. Subcontracts

7.1. The Bidder may subcontract portions of the Project to the extent allowed by the

Procuring Entity as stated herein, but in no case more than twenty percent (20%)

of the Project.

The Procuring Entity has prescribed that:

[Select one, delete other/s]

a. Subcontracting is allowed. The portions of Project and the maximum

percentage allowed to be subcontracted are indicated in the BDS, which

shall not exceed twenty percent (20%) of the contracted Goods.

15

b. Subcontracting is not allowed.

7.2. [If Procuring Entity has determined that subcontracting is allowed during the

bidding, state:] The Bidder must submit together with its Bid the documentary

requirements of the subcontractor(s) complying with the eligibility criteria

stated in ITB Clause 5 in accordance with Section 23.4 of the 2016 revised IRR

of RA No. 9184 pursuant to Section 23.1 thereof.

7.3. [If subcontracting is allowed during the contract implementation stage, state:]

The Supplier may identify its subcontractor during the contract implementation

stage. Subcontractors identified during the bidding may be changed during the

implementation of this Contract. Subcontractors must submit the documentary

requirements under Section 23.1 of the 2016 revised IRR of RA No. 9184 and

comply with the eligibility criteria specified in ITB Clause 5 to the

implementing or end-user unit.

7.4. Subcontracting of any portion of the Project does not relieve the Supplier of any

liability or obligation under the Contract. The Supplier will be responsible for

the acts, defaults, and negligence of any subcontractor, its agents, servants, or

workmen as fully as if these were the Supplier’s own acts, defaults, or

negligence, or those of its agents, servants, or workmen.

8. Pre-Bid Conference

The Procuring Entity will hold a pre-bid conference for this Project on the specified

date and time through videoconferencing/webcasting as indicated in paragraph 6 of the

IB.

9. Clarification and Amendment of Bidding Documents

Prospective bidders may request for clarification on and/or interpretation of any part of

the Bidding Documents. Such requests must be in writing and received by the

Procuring Entity, either at its given address or through electronic mail indicated in the

IB, at least ten (10) calendar days before the deadline set for the submission and receipt

of Bids.

10. Documents comprising the Bid: Eligibility and Technical Components

10.1. The first envelope shall contain the eligibility and technical documents of the

Bid as specified in Section VIII (Checklist of Technical and Financial

Documents).

10.2. The Bidder’s SLCC as indicated in ITB Clause 5.3 should have been completed

within two (2) years prior to the deadline for the submission and receipt of bids.

10.3. If the eligibility requirements or statements, the bids, and all other documents

for submission to the BAC are in foreign language other than English, it must

be accompanied by a translation in English, which shall be authenticated by the

appropriate Philippine foreign service establishment, post, or the equivalent

office having jurisdiction over the foreign bidder’s affairs in the Philippines.

16

Similar to the required authentication above, for Contracting Parties to the

Apostille Convention, only the translated documents shall be authenticated

through an apostille pursuant to GPPB Resolution No. 13-2019 dated 23 May

2019. The English translation shall govern, for purposes of interpretation of the

bid.

11. Documents comprising the Bid: Financial Component

11.1. The second bid envelope shall contain the financial documents for the Bid as

specified in Section VIII (Checklist of Technical and Financial Documents).

11.2. If the Bidder claims preference as a Domestic Bidder or Domestic Entity, a

certification issued by DTI shall be provided by the Bidder in accordance with

Section 43.1.3 of the 2016 revised IRR of RA No. 9184.

11.3. Any bid exceeding the ABC indicated in paragraph 1 of the IB shall not be

accepted.

11.4. For Foreign-funded Procurement, a ceiling may be applied to bid prices

provided the conditions are met under Section 31.2 of the 2016 revised IRR of

RA No. 9184.

11.5. [Include if Framework Agreement will be used:] Financial proposals for single

or multi-year Framework Agreement shall be submitted before the deadline of

submission of bids as prescribed in the IB. For multi-year Framework

Agreement, evaluation of the financial proposal during this stage is for purposes

of determining eligibility and whether or not such financial proposal is within

the ABC.

12. Bid Prices

12.1. Prices indicated on the Price Schedule shall be entered separately in the

following manner:

a. For Goods offered from within the Procuring Entity’s country:

i. The price of the Goods quoted EXW (ex-works, ex-factory, ex-

warehouse, ex-showroom, or off-the-shelf, as applicable);

ii. The cost of all customs duties and sales and other taxes already

paid or payable;

iii. The cost of transportation, insurance, and other costs incidental to

delivery of the Goods to their final destination; and

iv. The price of other (incidental) services, if any, listed in e.

b. For Goods offered from abroad:

i. Unless otherwise stated in the BDS, the price of the Goods shall

be quoted delivered duty paid (DDP) with the place of destination

17

in the Philippines as specified in the BDS. In quoting the price,

the Bidder shall be free to use transportation through carriers

registered in any eligible country. Similarly, the Bidder may

obtain insurance services from any eligible source country.

ii. The price of other (incidental) services, if any, as listed in Section

VII (Technical Specifications).

12.2. [Include if Framework Agreement will be used:] For Framework Agreement,

the following should also apply in addition to Clause 12.1:

a. For a single year Framework Agreement, the prices quoted by the Bidder

shall be fixed during the Bidder’s performance of the contract and not

subject to variation or escalation on any account. Price schedules required

under Clause 12.1 shall be submitted with the bidding documents.

b. For a multi-year Framework Agreement, the prices quoted by the Bidder

during submission of eligibility documents shall be the ceiling and the price

quoted during mini-competition must not exceed the initial price offer. The

price quoted during call for mini-competition shall be fixed during the

Bidder’s performance of that Call-off and not subject to variation or

escalation on any account. Price schedules required under Clause 12.1 shall

be submitted with the bidding documents.

13. Bid and Payment Currencies

13.1. For Goods that the Bidder will supply from outside the Philippines, the bid

prices may be quoted in the local currency or tradeable currency accepted by the

BSP at the discretion of the Bidder. However, for purposes of bid evaluation,

Bids denominated in foreign currencies, shall be converted to Philippine

currency based on the exchange rate as published in the BSP reference rate

bulletin on the day of the bid opening.

13.2. Payment of the contract price shall be made in:

a. Philippine Pesos.

14. Bid Security

14.1. The Bidder shall submit a Bid Securing Declaration1 or any form of Bid Security

in the amount indicated in the BDS, which shall be not less than the percentage

of the ABC in accordance with the schedule in the BDS.

14.2. The Bid and bid security shall be valid until April 15, 2021. Any Bid not

accompanied by an acceptable bid security shall be rejected by the Procuring

Entity as non-responsive.

1 In the case of Framework Agreement, the undertaking shall refer to entering into contract with the Procuring Entity and

furnishing of the performance security or the performance securing declaration within ten (10) calendar days from receipt of Notice to Execute Framework Agreement.

18

14.3. [Include if Framework Agreement will be used:] In the case of Framework

Agreement, other than the grounds for forfeiture under the 2016 revised IRR,

the bid security may also be forfeited if the successful bidder fails to sign the

Framework Agreement, or fails to furnish the performance security or

performance securing declaration. Without prejudice on its forfeiture, bid

securities shall be returned only after the posting of performance security or

performance securing declaration, as the case may be, by the winning Bidder or

compliant Bidders and the signing of the Framework Agreement.

15. Sealing and Marking of Bids

Each Bidder shall submit original and one copy of the first and second components of

its Bid.

The Procuring Entity may request additional hard copies and/or electronic copies of the

Bid. However, failure of the Bidders to comply with the said request shall not be a

ground for disqualification.

If the Procuring Entity allows the submission of bids through online submission or any

other electronic means, the Bidder shall submit an electronic copy of its Bid, which

must be digitally signed. An electronic copy that cannot be opened or is corrupted shall

be considered non-responsive and, thus, automatically disqualified.

16. Deadline for Submission of Bids

16.1. The Bidders shall submit on the specified date and time and either at its physical

address or through online submission as indicated in paragraph 7 of the IB.

16.2. [Include if Framework Agreement will be used:] For multi-year Framework

Agreement, the submission of bids shall be for the initial evaluation of their

technical and financial eligibility. Thereafter, those declared eligible during the

said initial eligibility evaluation and entered into a Framework Agreement with

the Procuring Entity shall submit anew their best financial offer at the address

and on or before the date and time indicated in the Call for each mini-

competition.

17. Opening and Preliminary Examination of Bids

17.1. The BAC shall open the Bids in public at the time, on the date, and at the place

specified in paragraph 9 of the IB. The Bidders’ representatives who are present

shall sign a register evidencing their attendance. In case videoconferencing,

webcasting or other similar technologies will be used, attendance of participants

shall likewise be recorded by the BAC Secretariat.

In case the Bids cannot be opened as scheduled due to justifiable reasons, the

rescheduling requirements under Section 29 of the 2016 revised IRR of RA No.

9184 shall prevail.

17.2. The preliminary examination of bids shall be governed by Section 30 of the

2016 revised IRR of RA No. 9184.

19

18. Domestic Preference

18.1. The Procuring Entity will grant a margin of preference for the purpose of

comparison of Bids in accordance with Section 43.1.2 of the 2016 revised IRR

of RA No. 9184.


Agreement, determination of margin of preference shall be conducted every

call for Mini-Competition.

19. Detailed Evaluation and Comparison of Bids

19.1. The Procuring BAC shall immediately conduct a detailed evaluation of all Bids

rated “passed,” using non-discretionary pass/fail criteria. The BAC shall

consider the conditions in the evaluation of Bids under Section 32.2 of the 2016

revised IRR of RA No. 9184.

[Include the following options if Framework Agreement will be used:]

a. In the case of single-year Framework Agreement, the Lowest Calculated

Bid shall be determined outright after the detailed evaluation;

b. For multi-year Framework Agreement, the determination of the eligibility

and the compliance of bidders with the technical and financial aspects of

the projects shall be initially made by the BAC, in accordance with Item

7.4.2 of the Guidelines on the Use of Framework Agreement.

19.2. If the Project allows partial bids, bidders may submit a proposal on any of the

lots or items, and evaluation will be undertaken on a per lot or item basis, as

the case maybe. In this case, the Bid Security as required by ITB Clause 15 shall

be submitted for each lot or item separately.

19.3. The descriptions of the lots or items shall be indicated in Section VII (Technical

Specifications), although the ABCs of these lots or items are indicated in the

BDS for purposes of the NFCC computation pursuant to Section 23.4.2.6 of the

2016 revised IRR of RA No. 9184. The NFCC must be sufficient for the total

of the ABCs for all the lots or items participated in by the prospective Bidder.

19.4. The Project shall be awarded as follows:

[Select one, delete the other/s]

Option 1 – One Project having several items that shall be awarded as one

contract.

Option 2 – One Project having several items grouped into several lots, which

shall be awarded as separate contracts per lot.

Option 3 - One Project having several items, which shall be awarded as separate

contracts per item.

20

[Delete Options 2 and 3 if Framework Agreement will be used.]

19.5. Except for bidders submitting a committed Line of Credit from a Universal or

Commercial Bank in lieu of its NFCC computation, all Bids must include the

NFCC computation pursuant to Section 23.4.1.4 of the 2016 revised IRR of RA

No. 9184, which must be sufficient for the total of the ABCs for all the lots or

items participated in by the prospective Bidder. For bidders submitting the

committed Line of Credit, it must be at least equal to ten percent (10%) of the

ABCs for all the lots or items participated in by the prospective Bidder.

20. Post-Qualification


Agreement, all bidders initially determined to be eligible and financially

compliant shall be subject to initial post-qualification. The BAC shall then

recommend the execution of a Framework Agreement among all eligible,

technically and financially compliant bidders and the Procuring Entity and shall

be issued by HoPE a Notice to Execute Framework Agreement. The

determination of the Lowest Calculated Bid (LCB) shall not be performed by

the BAC until a Mini-Competition is conducted among the bidders who

executed a Framework Agreement. When a Call for Mini-Competition is made,

the BAC shall allow the bidders to submit their best financial proposals on such

pre-scheduled date, time and place to determine the bidder with the LCB.

20.2. Within a non-extendible period of five (5) calendar days from receipt by the

Bidder of the notice from the BAC that it submitted the Lowest Calculated Bid,

{[Include if Framework Agreement will be used:] or in the case of multi-year

Framework Agreement, that it is one of the eligible bidders who have submitted

bids that are found to be technically and financially compliant,}the Bidder shall

submit its latest income and business tax returns filed and paid through the BIR

Electronic Filing and Payment System (eFPS) and other appropriate licenses

and permits required by law and stated in the BDS. {[Include if Framework

Agreement will be used:] For every mini-competition in Framework

Agreement, the LCB shall likewise submit the required documents for final Post

Qualification.}

21. Signing of the Contract

21.1. The documents required in Section 37.2 of the 2016 revised IRR of RA No.

9184 shall form part of the Contract. Additional Contract documents are

indicated in the BDS.

[Include the following clauses if Framework Agreement will be used:]

21.2. At the same time as the Procuring Entity notifies the successful Bidder that its

bid has been accepted, the Procuring Entity shall send the Framework

Agreement Form to the Bidder, which contract has been provided in the Bidding

Documents, incorporating therein all agreements between the parties.

21.3. Within ten (10) calendar days from receipt of the Notice to Execute Framework

Agreement with the Procuring Entity, the successful Bidder or its duly

21

authorized representative shall formally enter into a Framework Agreement

with the procuring entity for an amount of One Peso to be paid to the procuring

entity as a consideration for the option granted by the procuring entity to procure

the items in the Framework Agreement List when the need arises.

21.4. The Procuring Entity shall enter into a Framework Agreement with the

successful Bidder within the same ten (10) calendar day period provided that all

the documentary requirements are complied with.

21.5. The following documents shall form part of the Framework Agreement:

a. Framework Agreement Form;

b. Bidding Documents;

c. Call-offs;

d. Winning bidder’s bid, including the Technical and Financial Proposals, and

all other documents/statements submitted (e.g., bidder’s response to

request for clarifications on the bid), including corrections to the bid, if any,

resulting from the Procuring Entity’s bid evaluation;

e. Performance Security or Performance Securing Declaration, as the case

may be;

f. Notice to Execute Framework Agreement; and

g. Other contract documents that may be required by existing laws and/or

specified in the BDS.

22

Section III. Bid Data Sheet

Notes on the Bid Data Sheet

The Bid Data Sheet (BDS) consists of provisions that supplement, amend, or specify in

detail, information, or requirements included in the ITB found in Section II, which are

specific to each procurement.

This Section is intended to assist the Procuring Entity in providing the specific information

in relation to corresponding clauses in the ITB and has to be prepared for each specific

procurement.

The Procuring Entity should specify in the BDS information and requirements specific to

the circumstances of the Procuring Entity, the processing of the procurement, and the bid

evaluation criteria that will apply to the Bids. In preparing the BDS, the following aspects

should be checked:

a. Information that specifies and complements provisions of the ITB must be

incorporated.

b. Amendments and/or supplements, if any, to provisions of the ITB as necessitated by

the circumstances of the specific procurement, must also be incorporated.

23

Bid Data Sheet ITB

Clause

5.3 For this purpose, contracts similar to the Project shall be:

a. Supply and delivery of Drugs and Medicine.

b. completed within two (2) years prior to the deadline for the submission

and receipt of bids.

7.1 [Specify the portions of Goods to be subcontracted, which shall not be a

significant or material component of the Project as determined by the Procuring

Entity.]

12 The price of the Goods shall be quoted DDP [state place of destination] or the

applicable International Commercial Terms (INCOTERMS) for this Project.

14.1 The bid security shall be in the form of a Bid Securing Declaration, or any of the

following forms and amounts:

a. The amount of not less than 617,055.44 [Indicate the amount equivalent

to two percent (2%) of ABC], if bid security is in cash,

cashier’s/manager’s check, bank draft/guarantee or irrevocable letter of

credit; or

b. The amount of not less than 1,542,638.60 [Indicate the amount

equivalent to five percent (5%) of ABC] if bid security is in Surety Bond.

19.3 [In case the Project will be awarded by lot, list the grouping of lots by specifying

the group title, items, and the quantity for every identified lot, and the

corresponding ABC for each lot.]

[In case the project will be awarded by item, list each item indicating its quantity

and ABC.]

20.2 [List here any licenses and permits relevant to the Project and the corresponding

law requiring it.]

21.2 [List here any additional contract documents relevant to the Project that may be

required by existing laws and/or the Procuring Entity.]

24

Section IV. General Conditions of Contract

Notes on the General Conditions of Contract

The General Conditions of Contract (GCC) in this Section, read in conjunction with the

Special Conditions of Contract in Section V and other documents listed therein, should be a

complete document expressing all the rights and obligations of the parties.

Matters governing performance of the Supplier, payments under the contract, or matters

affecting the risks, rights, and obligations of the parties under the contract are included in

the GCC and Special Conditions of Contract.

Any complementary information, which may be needed, shall be introduced only through

the Special Conditions of Contract.

25

1. Scope of Contract

This Contract shall include all such items, although not specifically mentioned, that can

be reasonably inferred as being required for its completion as if such items were

expressly mentioned herein. All the provisions of RA No. 9184 and its 2016 revised

IRR, including the Generic Procurement Manual, and associated issuances, constitute

the primary source for the terms and conditions of the Contract, and thus, applicable in

contract implementation. Herein clauses shall serve as the secondary source for the

terms and conditions of the Contract.

This is without prejudice to Sections 74.1 and 74.2 of the 2016 revised IRR of RA No.

9184 allowing the GPPB to amend the IRR, which shall be applied to all procurement

activities, the advertisement, posting, or invitation of which were issued after the

effectivity of the said amendment.

Additional requirements for the completion of this Contract shall be provided in the

Special Conditions of Contract (SCC).

2. Advance Payment and Terms of Payment

2.1. Advance payment of the contract amount is provided under Annex “D” of the

revised 2016 IRR of RA No. 9184.

2.2. The Procuring Entity is allowed to determine the terms of payment on the partial

or staggered delivery of the Goods procured, provided such partial payment

shall correspond to the value of the goods delivered and accepted in accordance

with prevailing accounting and auditing rules and regulations. The terms of

payment are indicated in the SCC.

[Include the following clauses if Framework Agreement will be used:]

2.3. For a single-year Framework Agreement, prices charged by the Supplier for

Goods delivered and/or services performed under a Call-Off shall not vary from

the prices quoted by the Supplier in its bid.

2.4. For multi-year Framework Agreement, prices charged by the Supplier for

Goods delivered and/or services performed under a Call-Off shall not vary from

the prices quoted by the Supplier during conduct of Mini-Competition.

3. Performance Security

Within ten (10) calendar days from receipt of the Notice of Award by the Bidder from

the Procuring Entity but in no case later than prior to the signing of the Contract by

both parties, the successful Bidder shall furnish the performance security in any of the

forms prescribed in Section 39 of the 2016 revised IRR of RA No. 9184.{[Include if

Framework Agreement will be used:] In the case of Framework Agreement, the Bidder

may opt to furnish the performance security or a Performance Securing Declaration as

defined under the Guidelines on the Use of Framework Agreement.}

26

4. Inspection and Tests

The Procuring Entity or its representative shall have the right to inspect and/or to test

the Goods to confirm their conformity to the Project {[Include if Framework Agreement

will be used:] or Framework Agreement} specifications at no extra cost to the Procuring

Entity in accordance with the Generic Procurement Manual. In addition to tests in the

SCC, Section IV (Technical Specifications) shall specify what inspections and/or

tests the Procuring Entity requires, and where they are to be conducted. The Procuring

Entity shall notify the Supplier in writing, in a timely manner, of the identity of any

representatives retained for these purposes.

All reasonable facilities and assistance for the inspection and testing of Goods,

including access to drawings and production data, shall be provided by the Supplier to

the authorized inspectors at no charge to the Procuring Entity.

5. Warranty

5.1 In order to assure that manufacturing defects shall be corrected by the Supplier,

a warranty shall be required from the Supplier as provided under Section 62.1

of the 2016 revised IRR of RA No. 9184.

5.2 The Procuring Entity shall promptly notify the Supplier in writing of any claims

arising under this warranty. Upon receipt of such notice, the Supplier shall,

repair or replace the defective Goods or parts thereof without cost to the

Procuring Entity, pursuant to the Generic Procurement Manual.

6. Liability of the Supplier

The Supplier’s liability under this Contract shall be as provided by the laws of the

Republic of the Philippines.

If the Supplier is a joint venture, all partners to the joint venture shall be jointly and

severally liable to the Procuring Entity.

27

Section V. Special Conditions of Contract

Notes on the Special Conditions of Contract

Similar to the BDS, the clauses in this Section are intended to assist the Procuring Entity in

providing contract-specific information in relation to corresponding clauses in the GCC

found in Section IV.

The Special Conditions of Contract (SCC) complement the GCC, specifying contractual

requirements linked to the special circumstances of the Procuring Entity, the Procuring

Entity’s country, the sector, and the Goods purchased. In preparing this Section, the

following aspects should be checked:

a. Information that complements provisions of the GCC must be incorporated.

b. Amendments and/or supplements to provisions of the GCC as necessitated by the

circumstances of the specific purchase, must also be incorporated.

However, no special condition which defeats or negates the general intent and purpose of

the provisions of the GCC should be incorporated herein.

28

Special Conditions of Contract GCC

Clause

1 [List here any additional requirements for the completion of this Contract. The

following requirements and the corresponding provisions may be deleted,

amended, or retained depending on its applicability to this Contract:]

Delivery and Documents –

For purposes of the Contract, “EXW,” “FOB,” “FCA,” “CIF,” “CIP,” “DDP”

and other trade terms used to describe the obligations of the parties shall have

the meanings assigned to them by the current edition of INCOTERMS

published by the International Chamber of Commerce, Paris. The Delivery

terms of this Contract shall be as follows:

[For Goods supplied from abroad, state:] “The delivery terms applicable to the

Contract are DDP delivered [indicate place of destination]. In accordance with

INCOTERMS.”

[For Goods supplied from within the Philippines, state:] “The delivery terms

applicable to this Contract are delivered [indicate place of destination]. Risk

and title will pass from the Supplier to the Procuring Entity upon receipt and

final acceptance of the Goods at their final destination.”

Delivery of the Goods shall be made by the Supplier in accordance with the

terms specified in Section VI (Schedule of Requirements).

For purposes of this Clause the Procuring Entity’s Representative at the Project

Site is [indicate name(s)].

Incidental Services –

The Supplier is required to provide all of the following services, including

additional services, if any, specified in Section VI. Schedule of Requirements:

Select appropriate requirements and delete the rest.

a. performance or supervision of on-site assembly and/or start-up of

the supplied Goods;

b. furnishing of tools required for assembly and/or maintenance of the

supplied Goods;

c. furnishing of a detailed operations and maintenance manual for each

appropriate unit of the supplied Goods;

d. performance or supervision or maintenance and/or repair of the

supplied Goods, for a period of time agreed by the parties, provided

that this service shall not relieve the Supplier of any warranty

obligations under this Contract; and

29

e. training of the Procuring Entity’s personnel, at the Supplier’s plant and/or on-site, in assembly, start-up, operation, maintenance, and/or

repair of the supplied Goods.

f. [Specify additional incidental service requirements, as needed.]

The Contract price for the Goods shall include the prices charged by the

Supplier for incidental services and shall not exceed the prevailing rates charged

to other parties by the Supplier for similar services.

Spare Parts –

The Supplier is required to provide all of the following materials, notifications,

and information pertaining to spare parts manufactured or distributed by the

Supplier:

Select appropriate requirements and delete the rest.

a. such spare parts as the Procuring Entity may elect to purchase from the

Supplier, provided that this election shall not relieve the Supplier of any

warranty obligations under this Contract; and

b. in the event of termination of production of the spare parts:

i. advance notification to the Procuring Entity of the pending

termination, in sufficient time to permit the Procuring Entity to

procure needed requirements; and

ii. following such termination, furnishing at no cost to the Procuring

Entity, the blueprints, drawings, and specifications of the spare

parts, if requested.

The spare parts and other components required are listed in Section VI

(Schedule of Requirements) and the cost thereof are included in the contract

price.

The Supplier shall carry sufficient inventories to assure ex-stock supply of

consumable spare parts or components for the Goods for a period of [indicate

here the time period specified. If not used indicate a time period of three times

the warranty period].

Spare parts or components shall be supplied as promptly as possible, but in any

case, within [insert appropriate time period] months of placing the order.

30

Packaging –

The Supplier shall provide such packaging of the Goods as is required to prevent

their damage or deterioration during transit to their final destination, as

indicated in this Contract. The packaging shall be sufficient to withstand,

without limitation, rough handling during transit and exposure to extreme

temperatures, salt and precipitation during transit, and open storage. Packaging

case size and weights shall take into consideration, where appropriate, the

remoteness of the Goods’ final destination and the absence of heavy handling

facilities at all points in transit.

The packaging, marking, and documentation within and outside the packages

shall comply strictly with such special requirements as shall be expressly

provided for in the Contract, including additional requirements, if any, specified

below, and in any subsequent instructions ordered by the Procuring Entity.

The outer packaging must be clearly marked on at least four (4) sides as follows:

Name of the Procuring Entity

Name of the Supplier

Contract Description

Final Destination

Gross weight

Any special lifting instructions

Any special handling instructions

Any relevant HAZCHEM classifications

A packaging list identifying the contents and quantities of the package is to be

placed on an accessible point of the outer packaging if practical. If not practical

the packaging list is to be placed inside the outer packaging but outside the

secondary packaging.

Transportation –

Where the Supplier is required under Contract to deliver the Goods CIF, CIP,

or DDP, transport of the Goods to the port of destination or such other named

place of destination in the Philippines, as shall be specified in this Contract,

shall be arranged and paid for by the Supplier, and the cost thereof shall be

included in the Contract Price.

Where the Supplier is required under this Contract to transport the Goods to a

specified place of destination within the Philippines, defined as the Project Site,

transport to such place of destination in the Philippines, including insurance and

storage, as shall be specified in this Contract, shall be arranged by the Supplier,

and related costs shall be included in the contract price.

31

Where the Supplier is required under Contract to deliver the Goods CIF, CIP or

DDP, Goods are to be transported on carriers of Philippine registry. In the event

that no carrier of Philippine registry is available, Goods may be shipped by a

carrier which is not of Philippine registry provided that the Supplier obtains and

presents to the Procuring Entity certification to this effect from the nearest

Philippine consulate to the port of dispatch. In the event that carriers of

Philippine registry are available but their schedule delays the Supplier in its

performance of this Contract the period from when the Goods were first ready

for shipment and the actual date of shipment the period of delay will be

considered force majeure.

The Procuring Entity accepts no liability for the damage of Goods during transit

other than those prescribed by INCOTERMS for DDP deliveries. In the case

of Goods supplied from within the Philippines or supplied by domestic

Suppliers risk and title will not be deemed to have passed to the Procuring Entity

until their receipt and final acceptance at the final destination.

Intellectual Property Rights –

The Supplier shall indemnify the Procuring Entity against all third-party claims

of infringement of patent, trademark, or industrial design rights arising from use

of the Goods or any part thereof.

2.2 [If partial payment is allowed, state] “The terms of payment shall be as follows:

_____________.”

4 The inspections and tests that will be conducted are: [Indicate the applicable

inspections and tests]

32

Section VI. Schedule of Requirements

The delivery schedule expressed as weeks/months stipulates hereafter a delivery date which is

the date of delivery to the project site.

Item

Number Description Quantity Total

Delivered,

Weeks/Months

1 Procurement of Drugs and

Medicine

(Please see attached List of

items)

Within seven (7)

calendar days upon

receipt of the Notice

to Proceed

[Use this form for Framework Agreement:]

33

Framework Agreement List

Limited to repeatedly required goods and services that are identified to be necessary and

desirable, but, by its nature, use or characteristic, the quantity and/ or exact time of need cannot

be accurately pre-determined and are not advisable to be carried in stock.

Prepared by the End-User, attached to the APP and submitted to the BAC for the approval of

the HOPE.

FRAMEWORK AGREEMENT LIST

(AGENCY)

Item / Service

Type and nature of

each item/service

Cost per item or

service

Maximum Quantity Total Cost

per Item

TOTAL

(Approved Budget for

the Contract)

Expected delivery

timeframe after receipt

of a Call-Off.

Within [no. of days] calendar days upon issuance of Call-off .

Remarks Indicate here any other appropriate information as may be

necessary.

SIGNATURE OVER

PRINTED NAME

POSITION DEPARTMENT/DIVISION

34

Section VII. Technical Specifications

Notes for Preparing the Technical Specifications

A set of precise and clear specifications is a prerequisite for Bidders to respond realistically

and competitively to the requirements of the Procuring Entity without qualifying their Bids.

In the context of Competitive Bidding, the specifications (e.g. production/delivery schedule,

manpower requirements, and after-sales service/parts, descriptions of the lots or items) must

be prepared to permit the widest possible competition and, at the same time, present a clear

statement of the required standards of workmanship, materials, and performance of the

goods and services to be procured. Only if this is done will the objectives of transparency,

equity, efficiency, fairness , and economy in procurement be realized, responsiveness of bids

be ensured, and the subsequent task of bid evaluation and post-qualification facilitated. The

specifications should require that all items, materials and accessories to be included or

incorporated in the goods be new, unused, and of the most recent or current models, and that

they include or incorporate all recent improvements in design and materials unless otherwise

provided in the Contract.

Samples of specifications from previous similar procurements are useful in this respect. The

use of metric units is encouraged. Depending on the complexity of the goods and the

repetitiveness of the type of procurement, it may be advantageous to standardize the General

Technical Specifications and incorporate them in a separate subsection. The General

Technical Specifications should cover all classes of workmanship, materials, and equipment

commonly involved in manufacturing similar goods. Deletions or addenda should then

adapt the General Technical Specifications to the particular procurement.

Care must be taken in drafting specifications to ensure that they are not restrictive. In the

specification of standards for equipment, materials, and workmanship, recognized Philippine

and international standards should be used as much as possible. Where other particular

standards are used, whether national standards or other standards, the specifications should

state that equipment, materials, and workmanship that meet other authoritative standards,

and which ensure at least a substantially equal quality than the standards mentioned, will

also be acceptable. The following clause may be inserted in the Special Conditions of

Contract or the Technical Specifications.

Sample Clause: Equivalency of Standards and Codes

Wherever reference is made in the Technical Specifications to specific standards and codes

to be met by the goods and materials to be furnished or tested, the provisions of the latest

edition or revision of the relevant standards and codes shall apply, unless otherwise

expressly stated in the Contract. Where such standards and codes are national or relate to a particular country or region, other authoritative standards that ensure substantial equivalence

to the standards and codes specified will be acceptable.

Reference to brand name and catalogue number should be avoided as far as possible; where

unavoidable they should always be followed by the words “or at least equivalent.”

References to brand names cannot be used when the funding source is the GOP.

35

Where appropriate, drawings, including site plans as required, may be furnished by the

Procuring Entity with the Bidding Documents. Similarly, the Supplier may be requested to

provide drawings or samples either with its Bid or for prior review by the Procuring Entity

during contract execution.

Bidders are also required, as part of the technical specifications, to complete their statement

of compliance demonstrating how the items comply with the specification.

36

Technical Specifications

Item Specification Statement of Compliance

[Bidders must state here either “Comply”

or “Not Comply” against each of the

individual parameters of each

Specification stating the corresponding

performance parameter of the equipment

offered. Statements of “Comply” or “Not

Comply” must be supported by evidence in

a Bidders Bid and cross-referenced to that

evidence. Evidence shall be in the form of

manufacturer’s un-amended sales

literature, unconditional statements of

specification and compliance issued by the

manufacturer, samples, independent test

data etc., as appropriate. A statement that

is not supported by evidence or is

subsequently found to be contradicted by

the evidence presented will render the Bid

under evaluation liable for rejection. A

statement either in the Bidder's statement

of compliance or the supporting evidence

that is found to be false either during Bid

evaluation, post-qualification or the

execution of the Contract may be regarded

as fraudulent and render the Bidder or

supplier liable for prosecution subject to

the applicable laws and issuances.]

1 Procurement of Drugs and

Medicine

(Please see attached List of

Items)

[Use this form for Framework Agreement:]

37

Technical Specifications

TECHNICAL SPECIFICATIONS

Item /

Service

Maximum

Quantity

Technical

Specifications / Scope

of Work

Statement of Compliance

[Bidders must state here either

“Comply” or “Not Comply” against

each of the individual parameters of

each Specification stating the

corresponding performance

parameter of the equipment offered.

Statements of “Comply” or “Not

Comply” must be supported by

evidence in a Bidders Bid and cross-

referenced to that evidence. Evidence

shall be in the form of manufacturer’s

un-amended sales literature,

unconditional statements of

specification and compliance issued

by the manufacturer, samples,

independent test data etc., as

appropriate. A statement that is not

supported by evidence or is

subsequently found to be contradicted

by the evidence presented will render

the Bid under evaluation liable for

rejection. A statement either in the

Bidder's statement of compliance or

the supporting evidence that is found

to be false either during Bid

evaluation, post-qualification or the

execution of the Contract may be

regarded as fraudulent and render the

Bidder or supplier liable for

prosecution.]

38

Section VIII. Checklist of Technical and

Financial Documents

Notes on the Checklist of Technical and Financial Documents

The prescribed documents in the checklist are mandatory to be submitted in the Bid, but

shall be subject to the following:

a. GPPB Resolution No. 09-2020 on the efficient procurement measures during a State

of Calamity or other similar issuances that shall allow the use of alternate documents

in lieu of the mandated requirements; or

b. Any subsequent GPPB issuances adjusting the documentary requirements after the

effectivity of the adoption of the PBDs.

The BAC shall be checking the submitted documents of each Bidder against this checklist

to ascertain if they are all present, using a non-discretionary “pass/fail” criterion pursuant to

Section 30 of the 2016 revised IRR of RA No. 9184.

39

Checklist of Technical and Financial Documents

I. TECHNICAL COMPONENT ENVELOPE

Class “A” Documents

Legal Documents

⬜ (a) Valid PhilGEPS Registration Certificate (Platinum Membership) (all pages);

or

⬜ (b) Registration certificate from Securities and Exchange Commission (SEC),

Department of Trade and Industry (DTI) for sole proprietorship, or

Cooperative Development Authority (CDA) for cooperatives or its equivalent

document,

and

⬜ (c) Mayor’s or Business permit issued by the city or municipality where the

principal place of business of the prospective bidder is located, or the

equivalent document for Exclusive Economic Zones or Areas;

and

⬜ (d) Tax clearance per E.O. No. 398, s. 2005, as finally reviewed and approved

by the Bureau of Internal Revenue (BIR).

Technical Documents

⬜ (e) Statement of the prospective bidder of all its ongoing government and private

contracts, including contracts awarded but not yet started, if any, whether

similar or not similar in nature and complexity to the contract to be bid; and

⬜ (f) Statement of the bidder’s Single Largest Completed Contract (SLCC) similar

to the contract to be bid, except under conditions provided for in Sections

23.4.1.3 and 23.4.2.4 of the 2016 revised IRR of RA No. 9184, within the

relevant period as provided in the Bidding Documents; and

⬜ (g) Original copy of Bid Security. If in the form of a Surety Bond, submit also a

certification issued by the Insurance Commission;

or

Original copy of Notarized Bid Securing Declaration; and

⬜ (h) Conformity with the Technical Specifications, which may include

production/delivery schedule, manpower requirements, and/or after-

sales/parts, if applicable; and

⬜ (i) Original duly signed Omnibus Sworn Statement (OSS);

and if applicable, Original Notarized Secretary’s Certificate in case of a

corporation, partnership, or cooperative; or Original Special Power of

Attorney of all members of the joint venture giving full power and authority

to its officer to sign the OSS and do acts to represent the Bidder.

Financial Documents

⬜ (j) The Supplier’s audited financial statements, showing, among others, the

Supplier’s total and current assets and liabilities, stamped “received” by the

BIR or its duly accredited and authorized institutions, for the preceding

calendar year which should not be earlier than two (2) years from the date of

bid submission; and

⬜ (k) The prospective bidder’s computation of Net Financial Contracting Capacity

(NFCC);

40

or

A committed Line of Credit from a Universal or Commercial Bank in lieu of

its NFCC computation.

Class “B” Documents

⬜ (l) If applicable, a duly signed joint venture agreement (JVA) in case the joint

venture is already in existence;

or

duly notarized statements from all the potential joint venture partners stating

that they will enter into and abide by the provisions of the JVA in the instance

that the bid is successful.

Any other documents required:

1. Certificate of Product Registration (CPR)

2. PDEA, if applicable

3. CGMP or ISO

4. ARMMC Registration's Official Receipt (OR)

5. License to Operate (Drugs)

6. Certificate of Distributorship

7. Certificate of Satisfactory Performance from three (3) government hospitals for

the last two (2) years

II. FINANCIAL COMPONENT ENVELOPE

⬜ (m) Original of duly signed and accomplished Financial Bid Form; and

⬜ (n) Original of duly signed and accomplished Price Schedule(s).

Other documentary requirements under RA No. 9184 (as applicable)

⬜ (o) [For foreign bidders claiming by reason of their country’s extension of

reciprocal rights to Filipinos] Certification from the relevant government

office of their country stating that Filipinos are allowed to participate in

government procurement activities for the same item or product.

⬜ (p) Certification from the DTI if the Bidder claims preference as a Domestic

Bidder or Domestic Entity.

41

GPPB Resolution No. 14-2019, dated 17 July 2019 Page 4 of 20

ANNEX “A”

CIRCULAR 06-2019 17 July 2019 TO : Heads of Departments, Bureaus, Offices and Agencies of the

National Government, including State Universities and Colleges, Government-Owned or Controlled Corporations, Government Financial Institutions, and Local Government Units

SUBJECT : Guidelines on the Implementation of Early Procurement

Activities (EPA)

1. SCOPE AND APPLICATION

1.1 The Guidelines on Early Procurement Activities shall apply to Departments, Bureaus, Offices and Agencies of the National Government including State Universities and Colleges, Government-owned and/or Controlled Corporations (GOCCs), Government Financial Institutions, and Local Government Units (LGUs).

1.2 This Guidelines shall cover all types of procurement for goods, infrastructure

projects and consulting services funded out of or by the General Appropriations Act (GAA), appropriations ordinance, corporate budget, or loan agreement in case of Foreign-Assisted Projects (FAPs).

1.3 A Procurement Project shall refer to a specific or identified procurement

covering goods, infrastructure project or consulting services. A Procurement Project shall be described, detailed, and scheduled in the Project Procurement Management Plan prepared by the agency which shall be consolidated in the procuring entity's Annual Procurement Plan (APP).

1.4 EPA is applicable for Procurement Projects undertaken through Competitive

Bidding and Alternative Methods of Procurement, except for the following:

1.4.1 Repeat Order (Sec. 51); 1.4.2 Shopping (Sec. 52); 1.4.3 Negotiated Procurement- Emergency Cases (Sec. 53.2); 1.4.4 Negotiated Procurement- Take-Over of Contracts (Section 53.3); and 1.4.5 Negotiated Procurement - Small Value Procurement (Sec. 53.9).

1.5 Procurement Projects to be funded from lump-sum funds in the National Expenditure Program (NEP) wherein the recipients and the corresponding amounts have not been identified or approved, such as contingent funds, are excluded from the conduct of EPA, except those to be funded from:

Unit 2506 Raffles Corporate Center, F. Ortigas Jr. Road, Ortigas Center,

Pasig City, Philippines 1605


1.5.1 the Local Government Support Fund administered by the Department

of Interior and Local Government; and 1.5.2 the Budgetary Support to Government Corporations administered by the

Department of Budget and Management (DBM). 2. PREPARATORY ACTIVITIES

2.1 The procuring entity (PE) shall complete all the appropriate preparatory

activities such as, but not limited to, cost-benefit analysis, feasibility studies, market research, and detailed engineering designs, regulatory clearances and right of way acquisitions for civil works projects prior to the approval of the indicative APP.

2.2 The indicative APP must be duly approved by the Head of the Procuring Entity

(HoPE) and submitted to:

2.2.1 the DBM in case of national government agencies and GOCCs; 2.2.2 the respective governing boards for further approval in case of GOCCs

under the Governance Commission for GOCCs(GCG) and submission to the latter; or

2.2.3 the Sanggunian in case of LGUs. 2.3 The indicative APP shall be posted on the agency’s Transparency Seal

pursuant to DBM Circular Letter No. 2018- 8 dated 30 July 2018.

2.4 As clarified under Government Procurement Policy Board (GPPB) Circular 05-2018 dated 18 May 2018, the Certificate of Availability of Funds shall not be required prior to the commencement of EPA.

2.5 The PE shall expressly provide in the bidding documents and through

PhilGEPS posting that the Procurement Project is undertaken through EPA. The PE shall likewise ensure that the prospective bidders are properly informed, through the bidding documents and during the pre-bid conference, of all the implications of a Procurement Project undertaken through EPA. This shall include, but not limited to the:

2.5.1 rules and procedure of EPA; 2.5.2 fixed price rule in procurement; 2.5.3 extension of the bid validity and security; 2.5.4 validity of the eligibility requirements prior to the award of contract; 2.5.5 conditions of award; and 2.5.6 date of earliest delivery.

3. IMPLEMENTING GUIDELINES

3.1 EPA shall refer to the conduct of procurement activities, from posting of the procurement opportunity, if required, until recommendation of the Bids and Awards Committee (BAC) to the HoPE as to the award of the contract, for goods to be delivered, infrastructure projects to be implemented and consulting services to be rendered in the following fiscal year, pending approval of their respective funding sources.


3.2 The award of contract for Procurement Projects undertaken through EPA may be made only upon:

3.2.1 approval and effectivity of their respective funding sources, to wit: (i)

GAA; (ii) Corporate Budget; (iii) Appropriations Ordinance; or (iv) loan agreement in the case of FAPs; or

3.2.2 the reenactment of the previous year’s budget which constitutes the current year’s authorized budget, when authorized by the Constitution, law or rules.

3.3 PEs are encouraged to undertake EPA to ensure the timely delivery of goods,

implementation of infrastructure projects and rendition of consultancy services.

3.3.1 The conduct of EPA for nationally-funded Procurement Projects may commence as early as the submission of the NEP to Congress, usually in July. No EPA may be conducted without an indicative APP duly approved by the HoPE and the Multi-Year Contracting Authority (MYCA) issued by the DBM, in the case of multi-year projects.

3.3.2 For Procurement Projects funded by corporate and local funds, the EPA may be undertaken from the time the proposed corporate or local budget has been submitted to the approving authority.

3.3.3 In the case of Foreign-Assisted Projects, the same may commence: 3.3.3.1 from the approval of the National Economic and

Development Authority (NEDA) Board as evidenced by the official notice of approval issued by the NEDA Secretariat to the implementing agency; or

3.3.3.2 upon issuance of a document or instrument issued by the foreign donor or financing institution explicitly stating that a loan is to be made available to the Philippines, usually through the Department of Finance, or any of its agencies or instrumentalities with borrowing authority pending final approval of the loan.

3.4 Rules for Procurement Projects to be funded from a Source Agency and

Implemented by a Recipient Agency.

3.4.1 For Procurement Projects that are included in the budget of an agency (source agency) but shall be released directly to another agency (recipient agency) pursuant to a special provision in the NEP, the special provision shall be the basis of the recipient agency to conduct EPA. Such projects shall be included in the indicative APP of the recipient agency.

For example: Funds for the Basic Educational Facilities project under the Department of Education (DepEd) but is directly released to the Department of Public Works and Highways (DPWH), which shall implement the project. Funds for the Farm-to-Market Road Projects of the Department of Agriculture also directly released to the DPWH, which shall implement the project.


3.4.2 For Procurement Projects funded in the budget of an agency (source

agency) but to be implemented by another agency (recipient agency), a Memorandum of Understanding (MOU) between them shall be the basis of the recipient agency for the conduct of EPA. The MOU shall state that the source agency:

3.4.2.1 has proposed funds in the NEP for a Procurement Project; 3.4.2.2 identifies the recipient agency as the implementing unit for the said Procurement Project; and 3.4.2.3 authorizes the recipient agency to undertake EPA for the said Procurement Project.

Such Procurement Projects shall be included in the indicative APP of

the recipient agency. The MOU required above is limited to the conduct of EPA and is

different from the Memorandum of Agreement that may be required for the actual implementation of the Procurement Project under a special or general provision in the GAA, rules of the source or recipient agency, or budgeting, accounting and auditing rules and regulations.

3.4.3 For Procurement Projects funded by forthcoming sub-allotments from

the Central Office (CO) or Centrally-Managed Items, the written approval, in whatever form, from the CO identifying the implementing unit therefor with the corresponding amount and authorizing the conduct EPA shall be the basis for the conduct of said activity.

3.5 The source and recipient agencies shall ensure that any and all conditions or

documents required to be met or submitted as a prerequisite for the release of funds or sub-allotment thereof shall be timely prepared to enable the implementing agency to award the contract within the prescribed period.

4. BID VALIDITY

The PE may request the bidders to extend the validity of their bid securities beyond one hundred twenty (120) calendar days, prior to their expiration, if the funding source for the Procurement Project has yet to be approved and made effective.

A change in the form of the bid security is allowed if this is made prior to the expiration of the bid validity sought to be extended. If the bidder refuses to extend the bid validity, the PE shall reject the bid submitted by said bidder.

5. PROCUREMENT TIMELINES The conduct of EPA from posting to recommendation of the BAC to the HoPE as to the award of the contract shall observe the mandatory timelines set forth in the 2016 revised Implementing Rules and Regulations (IRR) of Republic Act No. (RA) No. 9184, including the period for re-bidding which shall be within fifteen (15) days after each


declaration of failure of bidding, which may be extended up to thirty (30) days upon approval of the HoPE.

6. REVISION OF THE INDICATIVE APP BEFORE AWARD OF CONTRACT 6.1. As soon as the funding source for the Procurement Project has been approved,

regardless of the stage of the EPA, the indicative APP shall be revised and approved in accordance with Section 7.2 of the 2016 revised IRR of RA No. 9184.

6.2. Upon approval of the APP and the commencement of the running of the period

to award the contract and complete the procurement process, the HoPE may approve or disapprove the recommendation of the BAC.

In case of approval, the HoPE shall issue the Notice of Award to the Lowest Calculated Responsive Bid or Highest Rated Responsive Bid, as the case may be, and thereafter sign the contract. In case of disapproval, the HoPE shall notify the BAC and the bidder in writing of such decision and the grounds thereof which shall be any of the grounds provided for under Section 41 of the 2016 revised IRR of RA No. 9184.

6.3. The final approved APP shall be submitted to the GPPB on or before the end

of January of the budget year, and shall be posted in accordance with Executive Order No. 662, series of 2007, as amended (refer to Appendix 1 for the revised APP form for the conduct of EPA).

7. AWARD OF CONTRACT 7.1. Notwithstanding the mandatory procurement timelines provided in Section 37

of RA No. 9184, Procurement Projects undertaken through EPA may be awarded upon approval and effectivity of the GAA, reenacted budget, appropriations ordinance, corporate budget or loan agreement, as the case may be.

For example: Agency A’s Approved Budget for the Contract (ABC)for its procurement of heavy duty shredders is 1 Million Pesos as authorized in the NEP and after undertaking EPA the contract price to be awarded amounts to 1 Million Pesos, Agency A may award the contract upon approval and effectivity of the GAA.

However, in the case of a reenacted budget, the PE may only

award the contract for Recurring Procurement Projects and not for new Procurement Projects. Recurring Procurement Projects shall refer to Procurement Projects included in the previous year’s budget which has been reenacted in or for the current year.

7.2. If the amount authorized for a Procurement Project has been reduced, the PE may still make an award if the contract price to be awarded is within the amount


authorized in the GAA, reenacted budget, appropriations ordinance, corporate budget, or loan agreement regardless of the posted ABC.

For example: Agency A’s ABC for its procurement of printers is 1.2 Million Pesos as authorized in the NEP and after undertaking EPA the contract price to be awarded is1 Million Pesos. If the budget is reduced to 1 Million Pesos, Agency A may award the contract because the contract price to be awarded is within the amount authorized.

7.3. The HoPE shall not award any Procurement Project if the amount therefor has

been withdrawn or in the event the amount authorized in the GAA, reenacted budget, appropriations ordinance, corporate budget, or loan agreement is lower than the amount of contract to be awarded.

For example:

a. Agency A’s ABC for its procurement of LED lighting system for its auditorium is 1.5 Million Pesos as authorized in the NEP and after undertaking EPA the contract price to be awarded is 1.3 Million Pesos. If the budget is withdrawn, Agency A shall NOT award the contract pursuant to Sec. 41(c) (iii) of the 2016 revised IRR of RA No. 9184.

b. Agency A’s ABC for its procurement of desktop computers is 1 Million Pesos as authorized in the NEP and after undertaking EPA the contract price to be awarded is PhP 900,000. If the budget is reduced to PhP 800,000, Agency A shall NOT award the contract pursuant to Sec. 41(c) (iii) of the 2016 revised IRR of RA No. 9184.

7.4. In all instances, the HoPE has the authority to exercise the reservation clause

under Section 41 of RA No. 9184, which grants the HoPE the right not to award the contract if, for any justifiable and reasonable ground, the award of the contract will not redound to the benefit of the government.

7.5. Notwithstanding the approval and effectivity of the GAA, reenacted budget, appropriations ordinance, corporate budget or loan agreement, as the case may be, PEs shall not award contracts for Procurement Projects requiring Special Allotment Release Order or Sub-Allotment Release Order until the same has been issued, secured or released.

8. TOLLING OR SUSPENSION OF THE PERIOD 8.1. Pursuant to Section 85 of Presidential Decree No. 1445 or the State Audit

Code, no contract involving the expenditure of public funds shall be entered into unless there is an appropriation. Accordingly, pending approval and effectivity of the GAA, corporate budget or appropriations ordinance, or the loan agreement in the case of FAPs, the following periods shall be tolled or suspended:


8.1.1 the fifteen-day (15 day) period for the HoPE to approve the Resolution of the BAC and to issue the Notice of Award provided under Section 37; and

8.1.2 the three-month (3-month) period within which to complete the procurement process, from the opening of bids up to the award of contract, under Section 38 of RA No. 9184.

8.2. The period of time for the award of contract and termination of the procurement

process, as the case may be, shall begin to run again upon the approval and effectivity of the GAA, reenacted budget, appropriations ordinance, corporate budget or loan agreement, as the case may be.

It shall not commence anew but rather, grants the HoPE the balance of the remaining period to award the contract or terminate the procurement process.

For example: The BAC conducted the Bid Opening on 30 July and the BAC issued a Resolution recommending award of the contract on 11 October. The 3-month period to complete the procurement process and the 15-day period for the HoPE to approve the contract are suspended beginning 12 October. The HoPE has seventeen (17) days to complete the procurement process from the approval and effectivity of the funding source. This is the period remaining from the 3-month period to complete the procurement process, i.e., 90 days less 73 days (or the period covering July 30 to October 11). If the approval and effectivity of the GAA is 1 January, the 3-month period to complete the procurement process and the 15-day period for the HoPE to approve the contract shall run again and the HoPE has (i) 15 days or until 16 January to award; and (ii) 17 days or until 18 January to complete the procurement process.

9. MONITORING

9.1 Annual Procurement Plan.

Projects undertaken through EPA shall be reported in the APP under a column separate from the regular procurement activities (refer to Appendix 1 for the revised APP form for the conduct of EPA).

9.2 Procurement Monitoring Report. Awards made under EPA shall be reported in the Procurement Monitoring Report (PMR) under a column separate from the regular procurement activities (refer to Appendix 2 for the revised PMR form for the conduct of EPA).

9.3 Agency Procurement Compliance and Performance Indicators (APCPI).


Under Indicator 9 on Compliance with Procurement Timeframes under Pillar III of the APCPI, the PE’s compliance shall be adjusted considering the tolling of the periods as allowed.

10. EFFECTIVITY

This Circular shall take effect immediately.

SGD LAURA B. PASCUA GPPB Chairperson Alternate

ITEM

NO ITEM DESCRIPTION QTY UNIT

UNIT COST

(PHP) TOTAL COST (PHP)

GROUP 1

ANESTHESIA PREPARATION

1 Atracurium Besylate 10mg/ml, 2.5 ml ampule (IV) 900 ampule 86.33 77,697.00

2Bupivacaine hydrochloride 0.5%, 10ml ampule

Isobaric325 ampule 103.00 33,475.00

3Bupivacaine hydrochloride 0.5%, 4ml (spinal),

heavy 800 vial 120.00 96,000.00

4Dantrolene (as sodium salt) 20mg ( with mannitol

3g/vial)12 vial 13,900.00 166,800.00

5 Diazepam 5mg tablet 50 ampule 9.29 464.50

6 Diazepam 5mg/ml, 2ml ampule 2,250 ampule 118.00 265,500.00

7 Ephedrine sulfate inj. 50mg/ml, 1 ml ampule 500 ampule 91.50 45,750.00

8 Esmolol (as hydrochloride) 10 mg/mL, 10 mL vial 60 vial 436.75 26,205.00

9 Fentanyl citrate 50mcg/ml, 2ml ampule IV 500 ampule 56.56 28,280.00

10 Isoflurane inhalation 100ml bottle 200 vial 1,409.11 281,822.00

11Ketamine hydrochloride inj. 50mg/ml, 10ml vial

(IM/IV)50 vial 455.61 22,780.50

12 Levobupivacaine 5mg/ml solution 10ml ampule 200 ampule 250.00 50,000.00

13 Midazolam 1mg/ml, 5ml ampule 1,500 ampule 103.69 155,535.00

14 Morphine sulfate 10mg/ml, 1ml ampule 500 ampule 63.00 31,500.00

15 Nalbuphine hhydrochloride 10mg/ml, 1ml ampule 500 ampule 53.44 26,720.00

16Neostigmine methyl sulfate inj. 500mcg/ml, 1ml

ampule300 ampule 118.75 35,625.00

17 Propofol inj 10mg/ml, 20 ml vial 1,000 vial 58.00 58,000.00

18 Propofol inj., 10mg/ml, 50 ml vial 25 vial 540.00 13,500.00

19 Remifentanil 1mg Lyophilized powder vial 100 vial 1,500.00 150,000.00

20 Rocuronium bromide 10 mg/ml, 5ml vial 400 vial 197.88 79,152.00

21Ropivacaine (as hydrochloride) 10mg / mL in 10

mL ampule200 ampule 405.00 81,000.00

22 Sevoflurane inhalation 250ml bottle 75 bottle 4,974.33 373,074.75

23 Sugammadex 100mg/mL, 2mL vial 60 vial 5,257.07 315,424.20

24Suxamethonium (Succinylcholine) 20 mg/mL, 10

mL vial25 vial 149.77 3,744.25

TOTAL 2,418,049.20

GROUP 2

CONTRAST MEDIA

25Contrast Media, Gadoteric Acid, 0.5 mmol/mL

Solution for Injection, 10 mL Glass Vial150 vial 2,860.00 429,000.00

26 Iohexol 300 mg iodine/mL, 100 mL Vial 25 vial 1,298.88 32,472.00



29Iopamidol 755 mg/mL equiv. to 370 mg iodine,

100 mL Vial 50 vial 1,904.12 95,206.00

TOTAL 663,124.00

GROUP 3

CHEMOTHERAPY DRUGS30 Bleomycin 15 mg vial 20 vial 1,750.00 35,000.00

31 Capecitabine 500 mg tablet 50 tablet 51.00 2,550.00

32 Cisplatin 1mg/ml, 50ml/ vial 150 vial 378.00 56,700.00

33 Cyclophosphamide 500mg powder vial 250 vial 156.00 39,000.00

34 Cytarabine 100mg/ml, 5ml vial 50 vial 381.50 19,075.00

35 Docetaxel 20 mg/ 0.5 ml, 0.5 ml vial 50 vial 1,110.25 55,512.50

36 Doxorubicin hydrochloride 50mg powder vial 150 vial 520.00 78,000.00

37 Filgrastim (G-CSF) 300 micrograms/mL, vial (IV, SC) 75 vial 1,026.69 77,001.75

38 Fluorouracil 50 mg/ml, 10 ml vial 400 vial 78.50 31,400.00

LIST OF ITEMS FOR DRUGS AND MEDICINE

39 Methotrexate 25 mg/mL, 2 mL Vial 50 vial 138.00 6,900.00

40Octreotide (as acetate) 100 ug/mL, 1 mL ampule

(IV infusion)100 ampule 540.00 54,000.00

41 Ondansetron 2mg/ml, 4ml ampule 150 ampule 129.88 19,482.00

42 Vincristine Sulfate 1 mg/mL, 2 mL Vial 50 vial 400.00 20,000.00

TOTAL 494,621.25

GROUP 4

GLUCOSE/ ELECTROLYTES43 Calcium gluconate 10%, 10ml vial/ampule 750 vial/ampule 16.83 12,622.50

IV FLUIDS

44I.V. Fluids, 0.9% Sodium Chloride 1 L Bottle ( PNSS

1L)20,000 bottle 40.94 818,800.00

45I.V. Fluids, 0.9% Sodium Chloride 50 mL Bottle (

PNSS 50cc)50 bottle 21.33 1,066.50

46I.V. Fluids, 0.9% Sodium Chloride 500 mL Bottle (

PNSS 500cc)250 bottle 90.00 22,500.00

47I.V. Fluids, 5% Dextrose in 0.3% Sodium Chloride

500 mL Bottle ( D5 0.3 NaCL 500 ml )1,000 bottle 33.00 33,000.00

48I.V. Fluids, 5% Dextrose in 0.9% Sodium Chloride 1

L Bottle (D5NSS 1L)1,000 bottle 39.94 39,940.00

49I.V. Fluids, 5% Dextrose in Lactated Ringer's 1 L

Bottle (D5 LR 1L)5,000 bottle 42.33 211,650.00

50I.V. Fluids, Balanced Multiple Maintenance

Solution with 5% Dextrose for Adult 1 L Bottle (D5

NM 1L )

1,500 bottle 44.80 67,200.00

51I.V. Fluids, Balanced Multiple Maintenance

Solution with 5% Dextrose for Pedia 500 mL Bottle

(D5 IMB 500ml)

4,000 bottle 42.34 169,360.00

52I.V. Fluids, Balanced Multiple Replacement

Solution with 5% Dextrose 1 L Bottle (D5 NR 1L)250 bottle 45.00 11,250.00

53I.V. Fluids, Lactated Ringer's Solution 1 L Bottle

(PLR 1L)7,500 bottle 43.45 325,875.00

54 Isotonic Electrolyte Sodium Chloride 1L 50 bottle 120.00 6,000.00

TOTAL 1,719,264.00

GROUP 5

EENT PREPARATIONS

55 Chlorhexidine Gluconate 0.12%, 120ml bottle 30 bottle 105.00 3,150.00

56 Clotrimazole Otic Drops 1% Solution 15ml 20 bottle 287.00 5,740.00

57Neomycin + Polymixin B+ Fluocinolone Acetonide

Ear Drops 5ml 15 bottle 190.00 2,850.00

58 Ofloxacin ear drops 0.3%, 5ml bottle 15 bottle 164.88 2,473.20

59 Oxymetazoline Nasal Drops 0.025%, 10ml bottle 25 bottle 255.50 6,387.50

OPTHALMOLOGIC PREPARATIONS

60 Atropine Sulfate eye drops solution 1%, 5ml bottle 15 bottle 283.00 4,245.00

61 Brimonidine opthlamic solution0.15% 5ml bottle 15 bottle 1,298.00 19,470.00

62 Brinzolamide opthalmic suspension 1% 5ml bottle 15 bottle 1,064.00 15,960.00

63 Carbachol opthalmic solution 0.01% 1.5ml vial 10 vial 150.00 1,500.00

64 Erythromycin eye ointment 0.5%, 3.5g tube 2.5 tube 124.24 310.60

65 Fluorescein inj. 10% (100mg/ml), 5 ml ampule 2.5 ampule 506.42 1,266.05

66Intraocular Irrigating Solution (Balanced Salt

Solution) 500 ml bottle2.5 bottle 500.00 1,250.00

67Latanoprost eye drops solution 50mcg/ml, 2.5 ml

bottle2.5 bottle 785.00 1,962.50

68Levofloxacin (0.5% w/v), 5mg/ml ophthalmic

solution25 bottle 373.60 9,340.00

69Moxifloxacin 5mg/ml (0.5% w/v) sterile

ophthalmic solution, 5 ml bottle25 bottle 320.00 8,000.00

70 Phenyleprine (as hydrocloride) 2.5% ,5 ml bottle 2.5 bottle 502.00 1,255.00

71 Pilocarpine (as hydrocloride) 1% 15ml bottle 6 bottle 299.50 1,797.00

72Prednisolone Acetate eye drop suspension 1% 5ml

bottle15 bottle 165.00 2,475.00

73Proxymetacaine (Proparacaine ) HCL eye drops

0.5% 15 ml bottle15 bottle 660.75 9,911.25

74Sodium Hyaluronase ophthalmic solution 0.1%

(1mg/ml), 5 ml bottle25 bottle 211.13 5,278.25

75Timolol maleate eye drops solution 0.5%, 5ml

bottle5 bottle 230.00 1,150.00

76Tobramycin + Dexamethasone eye ointment 0.3%

+ 0.1%, 3.5 g tube100 tube 493.90 49,390.00

77 Tobramycin eye drops solution 0.3%, 5ml bottle 25 bottle 300.00 7,500.00

78 Tobramycin eye ointment 0.3%, 3.5g tube 15 tube 453.33 6,799.95

79Tobramycin with dexamethasone eye drop

suspension 0.3%+ 0.1% 5ml bottle50 bottle 120.00 6,000.00

80Tropicamide with Phenylephrine Hydrochloride

5mg + 5 mg/ml eye drops fixed dose combination,

10 ml bottle

15 bottle 665.00 9,975.00

TOTAL 185,436.30

GROUP 6

PARENTERAL SOLUTION

81All-in-One Admixtures ("3-in-1" or "dual energy"

solutions) "3 in 1" 1400 Kcal Bottle 200 bag 1,988.00 397,600.00

82 Amino acid solution for infants 6%, 100ml bottle 500 bottle 492.80 246,400.00

TOTAL 644,000.00

GROUP 7

PSYCHIATRY DRUGS

83Fluphenazine (as decanoate) 25 mg/mL, 1

ml/ampule400 ampule 84.98 33,992.00

84 Olanzapine 10 mg tablet 500 tablet 4.25 2,125.00

85 Risperidone 2 mg tablet 50 tablet 4.65 232.50

86 Risperidone 2mg Orodispersible tablet 50 tablet 33.00 1,650.00

TOTAL 37,999.50

GROUP 8

SERA AND IMMUNOGLOBULINS

87Hepatitis B Immuniglobulin(human) 100 IU/0.5ml

vial50 vial 1,925.00 96,250.00

88Immunoglobulin, Normal, (human) (IGIV) 50

mg/mL, 50 mL Vial150 vial 4,399.00 659,850.00

89Immunoglobulin,Rabies (Equine) 200 IU/ml 5ml

vial , with local studies on its efficacy750 vial 1,183.92 887,940.00

90Immunoglobulin,Rabies (Human) 150 IU/ml 5ml

vial25 vial 300.00 7,500.00

91 Tetanus Antitoxin 1500 IU/ml ampule 4,000 ampule 65.00 260,000.00

92 Tetanus Toxoid 0.5ml amp 1,260 ampule 40.00 50,400.00

93Vaccine ,Rabies Vero Cell (Purified) 2.5IU/ml, WHO

Pre-qualified vial3,000 vial 1,165.00 3,495,000.00

94Vaccine,Rabies Chick Embryo Cell (Purified

Inactivated) 2.5IU/ml WHO Prequalified vial400 vial 1,209.00 483,600.00

TOTAL 5,940,540.00

GROUP 9- VARIOUS DRUGS AND MEDICINE

ANTI- VIRAL95 Aciclovir 400 mg tablet 50 tablet 30.50 1,525.00

96 Aciclovir 25mg/ml, 10ml vial 450 vial 977.43 439,843.50

97 Aciclovir 800mg tablet 50 tablet 56.07 2,803.50

98 Valaciclovir 500mg tablet 50 tablet 31.60 1,580.00

ANTI-ASTHMA99 Acetylcysteine 600mg effervescent tablet 1,000 tablet 22.00 22,000.00

100 Acetylcysteine IV 100mg/ml, 3ml ampule 40 ampule 115.00 4,600.00

101 Aminophylline 25mg/ml, 10ml ampule 25 ampule 23.09 577.25

102Budesonide + Formoterol 160 mcg + 4.5mcg

inhaler x 60 doses dry powder inhaler10 MDI 836.49 8,364.90

103Budesonide + Formoterol 80 mcg + 4.5mcg inhaler

x 60 doses dry powder inhaler15 MDI 731.09 10,966.35

104Budesonide 250mcg/ml 2ml respiratory

solution(nebule)750 nebule 38.75 29,062.50

105

Fluticasone (as propionate) + Salmeterol (as

xinafoate) MDI 250 micrograms fluticasone + 25

micrograms salmeterol x 120 actuations

150 MDI 300.00 45,000.00

106Indacaterol + Glycopyrronium 110mg + 50mg dry

powder capsule for inhalation750 capsule 62.48 46,860.00

107Ipratropium (as bromide) 500mcg + Salbutamol

2.5mg 2.5ml respiratory solution nebule2,230 nebule 12.00 26,760.00

108

Ipratropium (as bromide) Resp. Soln. (for

nebulization)

250 micrograms/mL, 2 mL (unit dose)

1,000 nebule 79.00 79,000.00

109 Montelukast sodium 10mg/tablet 50 tablet 5.00 250.00

110 Montelukast sodium 4mg/chewable tablet 50 tablet 6.00 300.00

111 Montelukast sodium 5mg/chewable tablet 50 tablet 7.00 350.00

112

Salbutamol (as sulfate) Metered Dose Inhaler

(MDI):

100 micrograms/dose x 200 actuations

1,000 MDI 85.84 85,840.00

113 Salbutamol sulfate 1mg/ml, 2.5ml nebule 5,000 nebule 8.00 40,000.00

114 Terbutaline Sulfate 500mcg/ml, 1ml 50 ampule 44.48 2,224.00

ANTIBIOTICS

116 Amikacin sulfate 250mg/ml, 2ml vial 50 vial 35.33 1,766.50

117 Amikacin sulfate 50mg/ml, 2ml vial 150 vial 20.33 3,049.50

118Amoxicillin trihydrate 100mg/ml, 15ml drops

bottle 72 bottle 38.45 2,768.40

119 Amoxicillin trihydrate 250mg capsule 500 capsule 2.31 1,155.00

120Amoxicillin trihydrate 250mg/5ml, 60ml

suspension bottle 50 bottle 60.00 3,000.00

121 Amoxicillin trihydrate 500mg capsule 50 capsule 1.28 64.00

122 Ampicillin + Sulbactam sodium 1.5 g vial 2000 vial 81.48 162,960.00

123 Ampicillin + Sulbactam sodium 500mg+250mg vial 1750 vial 24.00 42,000.00

124 Ampicillin sodium 1gm/vial 3000 vial 11.67 35,010.00

125 Ampicillin sodium 250mg/vial 500 vial 8.89 4,445.00

126 Ampicillin sodium 500mg/vial 5500 vial 8.21 45,155.00

127Azithromycin dihydrate 200mg/5ml, 15ml

suspension bottle 10 bottle 270.00 2,700.00

128 Azithromycin dihydrate 500mg/powder vial 650 vial 519.29 337,538.50

129 Azithromycin dihydrate 500mg/tablet 50 tablet 9.24 462.00

130 Cefalexin 500mg capsule 50 capsule 6.45 322.50

131 Cefazolin 1g vial 150 vial 17.88 2,682.00

132 Cefazolin 500mg vial 150 vial 28.77 4,315.50

133 Cefepime hydrochloride 1 gm vial 50 vial 93.22 4,661.00

134 Cefepime hydrochloride 500mg/vial 50 vial 148.73 7,436.50

135 Cefixime 200 mg capsule 500 capsule 9.06 4,530.00

136 Cefotaxime sodium 500mg/vial+2ml diluent 1250 vial 339.89 424,862.50

137 Ceftazidime pentahydrate 1gm/vial 500 vial 38.15 19,075.00

138 Ceftriaxone sodium 1gm/vial + 10ml diluent 9000 vial 19.94 179,460.00

139 Cefuroxime 500 mg tablet 5500 tablet 9.88 54,340.00

140 Cefuroxime sodium 1.5g vial 1000 vial 120.00 120,000.00

141Cefuroxime sodium 250 mg/5 mL granules for

suspension, 120 mL25 bottle 151.00 3,775.00

142 Cefuroxime sodium 750mg/vial 8500 vial 17.77 151,045.00

143 Ciprofloxacin 500mg tablet 500 tablet 6.00 3,000.00

144 Ciprofloxacin lactate 2mg/ml, 100ml vial 2500 vial 25.43 63,575.00

145 Clarithromycin 250 mg tablet 50 tablet 8.00 400.00

146 Clarithromycin 500mg tablet 5500 tablet 10.99 60,445.00

147 Clindamycin 150 mg/mL, 2 mL ampule/vial 4000 ampule/vial 361.70 1,446,800.00

148 Clindamycin 150mg capsule 250 capsule 3.90 975.00

149 Clindamycin 150mg/ml, 4ml ampule 1000 ampule 110.00 110,000.00

150 Clindamycin hydrochloride 300mg capsule 500 capsule 6.13 3,065.00

151Clindamycin palmitate hydrochloride 75mg/5ml,

60ml suspension bottle20 bottle 353.89 7,077.80

152 Cloxacillin 500mg capsule 1000 capsule 3.00 3,000.00

153Co-amoxiclav (Amoxicillin+Pottasium Clavunate)

500mg+125mg tablet4000 tablet 10.25 41,000.00

154Colistin 2,000,000 IU lyophilized powder for

injections (IV infusion) Restricted Antimicrobial150 vial 1,730.00 259,500.00

155

Cotrimoxazole (sulfamethazole + trimethoprim)

800 mg sulfamethoxazole + 160 mg trimethoprim

tablet

500 tablet 2.00 1,000.00

156Cotrimoxazole 400mg sulfamethoxazole + 80mg

trimethoprim/tablet50 tablet 1.03 51.50

157 Doxycycline 100mg/capsule 1000 capsule 15.00 15,000.00

158 Erythromycin 500mg/tablet 400 tablet 4.80 1,920.00

159 Fosfomycin 3 g granules for solution 50 bottle 429.00 21,450.00

160 Gentamicin 40mg/ml 2ml vial/ampule 1000 ampule/ vial 4.29 4,290.00

161 Levofloxacin 5 mg/mL solution, 100 mL vial 450 vial 122.12 54,954.00

162 Levofloxacin 500mg/tablet 50 tablet 8.00 400.00

163 Levofloxacin 750 mg tablet 250 tablet 21.55 5,387.50

164 Linezolid 2mg/ml (600mg/300ml) solution 15 bottle 3,850.00 57,750.00

165 Meropenem trihydrate 1 gm/powder vial 500 vial 169.33 84,665.00

166 Meropenem trihydrate 500mg/powder vial 500 vial 123.33 61,665.00

167 Metronidazole 500mg tablet 50 tablet 1.25 62.50

168 Metronidazole 5mg/ml, 100ml vial 3000 vial 14.94 44,820.00

169 Mupirocin 2% ointment, 5g tube 1000 tube 39.33 39,330.00

170 Nitrofurantoin 100mg/capsule 25 capsule 52.37 1,309.25

171 Nystatin 100,000 units/ml, 30ml suspension 50 bottle 160 8,000.00

172 Oxacillin sodium 500mg/vial 500 vial 18.89 9,445.00

173 Penicillin G Benzathine 1.2M units/vial 250 vial 51.33 12,832.50

174 Penicillin G crystalline sodium 1M units/vial 250 vial 6.36 1,590.00

175 Penicillin G crystalline sodium 5M units/vial 1000 vial 17.42 17,420.00

176 Phenoxymethyl penicilin 250mg/capsule 50 capsule 11.00 550.00

177 Phenoxymethyl penicillin 500mg/capsule 50 capsule 17.00 850.00

178Piperacillin + Tazobactam sodium 2gm+250mg/

vial 4500 vial 89.33 401,985.00

179Piperacillin + Tazobactam sodium 4gm+500mg/

vial8000 vial 108.50 868,000.00

180 Rifaximin 200 mg tablet 500 tablet 63.20 31,600.00

181 Silver Sulfadiazine Cream 1% ,15 g tube 50 tube 58.88 2,944.00

182 Sucralfate 1 g tablet 50 tablet 30.72 1,536.00

183 Tetracycline 500mg capsule 50 capsule 1.77 88.50

184 Vancomycin hydrochloride 1g vial 150 vial 344.30 51,645.00

185 Vancomycin hydrochloride 500mg vial 1500 vial 129.00 193,500.00

ANTICOAGULANT

186Enoxaparin (as sodium salt) 100 mg/mL, 0.4mL

pre‐filled syringe250 PFS 197.23 49,307.50

187Enoxaparin (as sodium salt) 100 mg/mL, 0.6mL

pre‐filled syringe2000 PFS 286.79 573,580.00

188Fondaparinux (as sodium salt) 2.5 mg/0.5 mL

solution40 vial 1,188.50 47,540.00

189 Heparin 1000iu/5ml vial 48 vial 48.83 2,343.84

190 Warfarin (as sodium salt) 2.5 mg tablet 50 tablet 13.00 650.00

191 Warfarin (as sodium salt) 5 mg tablet 50 tablet 12.80 640.00

ANTICONVULSANT

192 Clonazepam 2mg tablet 50 tablet 7.80 390.00

193 Divalproex Sodium 250 mg tablet 500 tablet 30.80 15,400.00

194 Gabapentin 100 mg capsule 50 capsule 5.90 295.00

195 Gabapentin 300 mg capsule 50 capsule 6.78 339.00

196 Levetiracetam 100mg/ml 300ml syrup 75 bottle 1,538.38 115,378.50

197 Levetiracetam 250mg tablet 250 tablet 35.25 8,812.50

198 Levetiracetam 500mg tablet 500 tablet 10.25 5,125.00

199 Levetiracetam 500mg/5ml 5ml vial 125 vial 2,088.00 261,000.00

200 Phenobarbital (as sodium salt) 15 mg tablet 100 tablet 2.60 260.00

201 Phenobarbital (as sodium salt) 30 mg tablet 250 tablet 2.88 720.00

202 Phenobarbital (as sodium salt) 90 mg tablet 250 tablet 9.75 2,437.50

203 Phenobarbital (as sodium salt)60 mg tablet 50 tablet 4.70 235.00

204 Phenobarbital 130mg/ml, 1ml ampule 100 ampule 509.28 50,928.00

205 Valproic acid 250mg/5ml syrup, 120ml bottle 25 bottle 314.05 7,851.25

206 Valproic acid 500mg/5ml, 5ml vial 50 vial 1,927.20 96,360.00

ANTIDOTES -

207 Activated Charcoal 25 grams 1,281.37 32,034.25

208 Atropine (as sulfate)1 mg/mL, 1 mL ampule500

ampule 13.67 6,835.00

ANTIFUNGAL -

209 Fluconazole 200mg capsule 250 capsule 333.35 83,337.50

210 Fluconazole 2mg/ml, 100ml vial 250 vial 386.33 96,582.50

ANTIHISTAMINE

211

Cetirizine dihydrochloride 10 mg/mL drops,

10 mL25

bottle 65.56 1,639.00

212 Cetirizine dihydrochloride 10mg tablet 1000 tablet 0.43 430.00

213

Cetirizine dihydrochloride 1mg/ml syrup,

60ml bottle25

bottle 62.00 1,550.00

214

Cetirizine dihydrochloride 2.5 mg/mL syrup

(oral drops), 10 mL50

bottle 187.50 9,375.00

215

Cetirizine dihydrochloride 5 mg/5 mL syrup,

30 mL25

bottle 70.00 1,750.00

216 Chlorphenamine (as maleate) 4 mg tablet 50 tablet 0.40 20.00

217Diphenhydramine (as hydrochloride) 50 mg

capsule50 capsule 1.21 60.50

218Diphenhydramine (as hydrochloride)

50mg/ml 1ml ampule1000 ampule 22.33 22,330.00

219Diphenhydramine hydrochloride 12.5mg/5ml

syrup, 60ml bottle15 bottle 19.00 285.00

220 Loratidine 10mg tablet 50 tablet 0.98 49.00

ANTIHYPERTENSIVE

221 Amlodipine besilate 10mg tablet 5,000 tablet 0.67 3,350.00

222 Amlodipine besilate 5mg tablet 7,500 tablet 0.47 3,525.00

223 Bisoprolol (as fumarate) 5 mg tablet 150 tablet 18.00 2,700.00

224 Captopril 25 mg tablet 750 tablet 3.00 2,250.00

225 Carvedilol 25 mg tablet 250 tablet 4.88 1,220.00

226 Carvedilol 6.25 mg tablet 1,500 tablet 1.38 2,070.00

227Clonidine 75 mcg tablet (in blister pack or

foil)500 tablet 5.99 2,995.00

228 Diltiazem (as hydrochloride) 60 mg tablet 50 tablet 19.00 950.00

229 Enalapril (as maleate) 5 mg tablet 150 tablet 4.82 723.00

230 Felodipine 5 mg MR tablet 50 tablet 7.95 397.50

231Hydralazine hydrochloride 20mg/ml, 1ml

ampule250 ampule 34.96 8,740.00

232Irbesartan + Hydrochlorothiazide 150 mg

irbesartan + 12.5 mg HCTZ tablet50 tablet 9.90 495.00

233 Irbesartan 150 mg tablet 50 tablet 3.75 187.50

234 Irbesartan 300 mg tablet 50 tablet 8.33 416.50

235 Isosorbide Dinitrate 1 mg/mL, 10 mL ampule 400 ampule 544.01 217,604.00

236 Isosorbide Dinitrate 5 mg tablet 500 tablet 8.25 4,125.00

237 Isosorbide-5-Mononitrate 30 mg MR tablet 1,000 tablet 11.10 11,100.00

238 Isosorbide-5-Mononitrate 60 mg MR tablet 500 tablet 7.21 3,605.00

239 Losartan (as potassium salt) 100 mg tablet 3,000 tablet 2.76 8,280.00

240Losartan + Hydrochlorothiazide 50 mg

losartan + 12.5 mg HCTZ tablet1,500 tablet 2.00 3,000.00

241 Losartan 50 mg tablet 7,500 tablet 0.80 6,000.00

242 Methyldopa 250 mg tablet 2,000 tablet 8.50 17,000.00

243 Metoprolol (as tartrate) 100 mg tablet 500 tablet 1.65 825.00

244 Metoprolol tartrate 50mg/ tablet 1,500 tablet 1.10 1,650.00

245Nicardipine hydrochloride 1mg/ml, 10ml

ampule9,000 ampule 145.83 1,312,470.00

246 Nifedipine 10 mg capsule 500 capsule 4.90 2,450.00

247 Nifedipine 30 mg MR tablet 250 tablet 29.11 7,277.50

248 Nimodipine 30 mg tablet 750 tablet 30.82 23,115.00

249 Propranolol (as hydrochloride) 40 mg tablet 500 tablet 10.00 5,000.00

250 Propranolol hydrochloride 10mg tablet 500 tablet 0.86 430.00

251 Sacubitril/Valsartan 100mg tablet 50 tablet 56.25 2,812.50



254Telmisartan + Hydrochlorothiazide 40 mg + 12.5

mg tablet500 tablet 17.17 8,585.00

255 Telmisartan 40 mg tablet 300 tablet 12.00 3,600.00

256 Telmisartan 80 mg tablet 500 tablet 24.89 12,445.00

257 Trimetazidine (as hydrochloride) 35 mg tablet 500 tablet 4.07 2,035.00

258Valsartan + Hydrochlorothiazide 80 mg valsartan +

12.5 mg HCTZ tablet1500 tablet 12.05 18,075.00

259 Valsartan 160 mg tablet/film coated tablet 250 tablet 13.39 3,347.50

260 Valsartan 80 mg tablet 2500 tablet 8.45 21,125.00

261Verapamil (as hydrochloride) 240 mg MR tablet

(for maintenance therapy)50 tablet 19.68 984.00

262 Verapamil (as hydrochloride) 80 mg tablet 50 tablet 32.63 1,631.50

ANTIPYRETIC/ANALGESIC /OPIOD

ANALGESIC/ANTIINFLAMMATORY263 Baclofen 10 mg tablet 250 tablet 18.00 4,500.00

264 Butorphanol 2mg/ml ampule/vial 250 ampule/vial 509.00 127,250.00

265 Celecoxib 200 mg capsule 750 capsule 3.96 2,970.00

266 Celecoxib 400 mg capsule 500 capsule 15.00 7,500.00

267 Diclofenac Sodium 50mg tablet 100 tablet 0.75 75.00

268 Eperisone hydrochloride 50 mg tablet 50 tablet 12.00 600.00

269 Ibuprofen Oral 200 mg tablet 50 tablet 0.94 47.00

270 Ibuprofen Oral 400 mg tablet 50 tablet 1.11 55.50

271Ketorolac tromethamol 30mg/ml, 1ml (IV/IM)

ampule1,500 ampule 15.87 23,805.00

272 Mefenamic acid 250mg/capsule/tablet 500

capsule/tabl

et

2.20 1,100.00

273 Mefenamic acid 500mg/capsule/tablet 5,000

capsule/tabl

et

1.39 6,950.00

274 Morphine (as sulfate) 10 mg tablet 50 tablet 24.24 1,212.00

275 Morphine (as sulfate) 30 mg tablet 50 tablet 71.07 3,553.50

276 Naproxen Sodium 550mg tablet 50 tablet 8.50 425.00

277 Paracetamol 10 mg/mL, 100 mL vial (IV infusion) 4,250 vial 133.80 568,650.00

278 Paracetamol 100mg/ml drops, 15ml/bottle 100 bottle 19.50 1,950.00

279 Paracetamol 10mg/mL, 50mL vial 50 vial 217.18 10,859.00

280Paracetamol 120mg/5ml and/or 125mg/5ml

syrup, 60ml bottle50 bottle 16.00 800.00

281 Paracetamol 125mg/suppository 100 suppository 17.33 1,733.00

282 Paracetamol 150mg/ml, 2ml ampule 13,330 ampule 4.43 59,051.90

283 Paracetamol 250mg/5ml syrup, 60ml/bottle 50 bottle 16.62 831.00

284 Paracetamol 500mg/tablet 500 tablet 0.40 200.00

285 Tramadol 100mg MR capsule 50 capsule 72.64 3,632.00

286 Tramadol 50mg capsule 3,000 capsule 2.50 7,500.00

287 Tramadol 50mg/ml 2ml ampule 4,000 ampule 9.84 39,360.00

ANTIVERTIGO

288Betahistine (as hydrochloride/ dihydrochloride) 16

mg tablet 500 tablet 28.25 14,125.00


mg tablet 750 tablet 40.00 30,000.00


mg tablet 250 tablet 10.99 2,747.50

291 Cinnarizine 25 mg tablet 500 tablet 2.30 1,150.00

CARDIAC DRUGS/ INOTROPES -

292 Amiodarone (as hydrochloride) 200 mg tablet 250 tablet 21.65 5,412.50

293 Amiodarone hydrochloride 50mg/ml, 3ml ampule 250 ampule 314.25 78,562.50

294 Digoxin 250 micrograms/mL, 2 mL ampule 50 ampule 118.34 5,917.00

295 Digoxin 250mcg/tablet 500 tablet 5.20 2,600.00

296 Dobutamine hydrochloride 50mg/ml, 5ml ampule 1,500 ampule 200.00 300,000.00

297 Dopamine hydrochloride 40mg/ml, 5ml ampule 1,000 ampule 41.89 41,890.00

298 Epinephrine hypdrochloride 1mg/ml, 1ml ampule 2,500 ampule 24.42 61,050.00

299 Norephineprine bitartrate 1mg/ml, 2ml ampule 1,000 ampule 98.88 98,880.00

300 Norepinephrine 1mg/mL, 4mL ampule 2,500 ampule 262.00 655,000.00

301 Potassium chloride 2mEq/ml, 20 ml vial 1,500 vial 30.00 45,000.00

302 Potassium Chloride 600 mg tablet 6,000 tablet 11.00 66,000.00

303 Potassium chloride 750mg/durule 7,500 tablet 15.00 112,500.00

MISCELLANOUS

304 Colchicine 500 microgram tablet 250 tablet 3.08 770.00

305 Hydroxyurea 500 mg capsule 250 capsule 18.96 4,740.00

306Mebendazole 100 mg/5 mL, 60mL Suspension

bottle40 bottle 17.00 680.00

307Oral Rehydration Salts (ORS-75 replacement)

4.1gm/sachet500 sachet 3.39 1,695.00

308 Permethrin Lotion 5%,60 ml bottle 12 bottle 231.00 2,772.00

309Pneumococcal Conjugate Vaccine 13- Valent ,

0.5mL pre-filled syringe25 PFS 450.00 11,250.00

310 Propylthiouracil 50mg/tablet 4,000 tablet 9.70 38,800.00

311 Sevelamer 800mg/tablet 2,500 tablet 38.79 96,975.00

312 Ursodeoxycholic acid 250mg/capsule 50 capsule 95.00 4,750.00

313 Ursodeoxycholic acid 300mg tablet/capsule 50 tablet/

capsule 10.80 540.00

OB PREPARATIONS -

314 Carboprost 125 mcg/0.5ml ampule 200 ampule 179.50 35,900.00

315 Carboprost 250 mcg/ampule 200 ampule 305.00 61,000.00

316 Isoxsuprine 10mg/tablet 500 tablet 6.17 3,085.00

317 Isoxsuprine 5mg/ml, 2ml ampule 750 ampule 169.00 126,750.00

318 Magnesium Sulfate 250mg/ml, 20ml vial 500 vial 55.98 27,990.00

319 Methylergometrine maleate 200mcg/ml/ ampule 1,000 ampule 16.60 16,600.00

320 Oxytocin 10 IU/ml, 1 ml/ampule 6,500 ampule 7.34 47,710.00

DIURETICS -

321 Acetazolamide 250 mg tablet 150 tablet 20.00 3,000.00

322 Furosemide 10mg/ml, 2ml ampule 11,500 ampule 6.33 72,795.00

323 Furosemide 20mg/tablet 500 tablet 1.30 650.00

324 Furosemide 40mg/tablet 250 tablet 0.60 150.00

325 Mannitol 20%, 500ml glass bottle 2,000 bottle 79.88 159,760.00

326 Spironolactone 25mg tablet 2,000 tablet 9.90 19,800.00

DOH VACCINES -

327 BCG 10 doses ampule 50 ampule 480.00 24,000.00

328Vaccine, Hepatitis B 10mcg/0.5ml (pediatric)

monodose vial 25 vial 133.72 3,343.00

DYSLIPIDAEMIC AGENTS -

329 Atorvastatin calcium 40 mg tablet 500 tablet 19.33 9,665.00

330 Atorvastatin calcium 80 mg tablet 500 tablet 22.00 11,000.00

331 Rosuvastatin (as calcium salt) 10 mg tablet 2,000 tablet 4.61 9,220.00

332 Rosuvastatin (as calcium salt) 20 mg tablet 4,000 tablet 7.06 28,240.00

GASTROINTESTINAL

333Aluminum Hydroxide + Magnesium Hydroxide

200mg + 100mg tablet 30 tablet 1.50 45.00

334Aluminum Hydroxide + Magnesium Hydroxide

225mg + 200mg/5ml Suspension 60ml100 bottle 39.00 3,900.00

335 Domperidone 10 mg tablet 50 tablet 5.00 250.00

336 Dydrogesterone 10mg / tablet 50 tablet 51.83 2,591.50

337 Hyoscine (as N-butyl bromide) 10 mg tablet 150 tablet 4.74 711.00

338Hyoscine (as N-butyl bromide) 20 mg/mL, 1 mL

ampule750 ampule 19.21 14,407.50

339Metoclopramide (as base and ashydrochloride) 10

mg tablet500 tablet 2.15 1,075.00

340 Metoclopromide 5mg/ml 2ml amp 2,250 ampule 3.98 8,955.00

HYPOTHYRODISM341 Calcium gluconate 10%, 20ml vial/ampule 20 vial/ampule 48.00 960.00

342 Glucose (Dextrose) 50%, 50 ml vial 1,500 vial 24.22 36,330.00

343 Sodium bicarbonate 1meq/ml, 50ml vial 750 vial 99.00 74,250.00

344 Sodium Bicarbonate 650 mg tablet 5,000 tablet 1.00 5,000.00

345 Sodium Chloride 2.5mEqs/ml, 20ml vial 250 vial 65.00 16,250.00

346Levothyroxine (as anhydrous sodium) 100mcg

tablet 50

tablet 8.08 404.00

347Levothyroxine (as anhydrous sodium) 50 mcg

tablet 50

tablet 3.60 180.00

INSULIN HYPOGLYCEMIA

348 Insulin regular 100 IU/ml,10ml vial 1,000 vial 89.00 89,000.00

349 Insulin, Isophane Human 100IU/ml, 10ml vial 500 vial 79.00 39,500.00

LAXATIVES350 Bisacodyl 10 mg (adult) suppository 250 suppository 35.00 8,750.00

351 Bisacodyl 5 mg tablet 500 tablet 1.85 925.00

352 Bisacodyl 5mg suppository 150 suppository 16.50 2,475.00

353 Castor Oil 60ml bottle 20 bottle 69.56 1,391.20

354 Lactulose 3.3g/5ml (66%) syrup 120ml 2,000 bottle 108.33 216,660.00

LOCAL ANESTHESIA - -

355 Lidocaine 2% ,1.8ml w/ Epinephrine Carpule 150 carpule 30.00 4,500.00

356 Lidocaine hydrochloride 2%, 50ml vial 1,000 vial 65.00 65,000.00

357 Lidocaine pump spray 10% 50 ml 10 bottle 2,461.62 24,616.20

ORAL HYPOGLYCEMIC AGENTS -

358 Gliclazide 30 mg MR tablet 50 tablet 2.50 125.00

359 Gliclazide 60 mg MR tablet 50 tablet 10.60 530.00

360 Gliclazide 80 mg tablet 50 tablet 3.20 160.00

361Metformin (as hydrochloride) 500 mg tablet/film

coated tablet10,000 tablet 0.88 8,800.00

PROTON PUMP INHIBITOR -

362 Famotidine 10 mg/mL, 2 mL ampule/vial 100 ampule/ vial 129.89 12,989.00

363 Omeprazole 20mg capsule 2,500 capsule 0.77 1,925.00

364 Omeprazole 40mg capsule 1,000 capsule 7.00 7,000.00

365Omeprazole 40mg/powder vial + 10ml solvent

ampule12,500 vial 29.12 364,000.00

366 Ranitidine 150mg tablet 50 tablet 0.80 40.00

367 Ranitidine 300mg tablet 50 tablet 2.10 105.00

368 Ranitidine hydrochloride 25mg/ml, 2ml ampule 1,250 ampule 3.89 4,862.50

STEROIDS369 Dexamethasone 4mg/tablet 500 tablet 26.67 13,335.00

370Dexamethasone sodium phosphate 4mg/ml, 2ml

vial2,500 vial 25.00 62,500.00

371Hydrocortisone sodium succinate 100mg powder

vial50 vial 21.06 1,053.00

372Hydrocortisone sodium succinate 250mg powder

vial750 vial 61.06 45,795.00

373Methylprednisolone (as sodium succinate) 16 mg

tablet250 tablet 8.50 2,125.00


tablet50 tablet 8.00 400.00


in single dose vial, solution for injection10 vial 669.00 6,690.00

376Methylprednisolone sodium succinate 1gm/16ml +

diluent vial75 vial 3,350.00 251,250.00

377 Methylprednisonlone 500mg/8.0ml + diluent vial 50 vial 3,796.51 189,825.50

378 Prednisone 10 mg/5 mL suspension, 60 mL 25 bottle 82.86 2,071.50

379 Prednisone 10mg tablet 500 tablet 2.47 1,235.00

380 Prednisone 20mg tablet 500 tablet 3.00 1,500.00

381 Prednisone 5mg tablet 50 tablet 0.95 47.50

THROMBOLYTIC382 Aspirin 100mg tablet 500 tablet 2.95 1,475.00

383 Aspirin 300mg tablet 500 tablet 3.25 1,625.00

384 Aspirin 80mg tablet 5,000 tablet 0.79 3,950.00

385Epoetin Alfa (recombinant human erythropoietin)

10000 IU/mL, pre-filled syringe150 PFS 1,500.00 225,000.00


2000 IU/0.5 mL, pre‐filled syringe125 PFS 250.00 31,250.00


4000 IU/0.4 mL, pre‐filled syringe5,000 PFS 406.00 2,030,000.00

388 Tranexamic Acid 100 mg/mL, 5 mL ampule 3,000 ampule 15.78 47,340.00

389 Tranexamic Acid 250 mg capsule 50 capsule 5.00 250.00

390 Tranexamic acid 500mg capsule/tablet 750 capsule/

tablet 5.76 4,320.00

VITAMINS/MINERALS

391 Ascorbic acid 100mg/5ml, 60ml syrup bottle 72 bottle 39.50 2,844.00

392 Ascorbic acid 100mg/ml, 15ml drops 50 bottle 50.00 2,500.00

393 Ascorbic acid 250 mg/ml, 2ml ampule 180 ampule 29.38 5,288.40

394 Ascorbic acid 500mg tablet 500 tablet 0.86 430.00

395 Calcium Carbonate 500 mg tablet 12,500 tablet 4.09 51,125.00

396 Calcium Carbonate 600mg tablet 50 tablet 4.00 200.00

397Calcium Carbonate + Cholecalciferol (vitamin D3)

Equiv. to 500 mg elemental Ca + 400 IU Vit. D3150 tablet 4.00 600.00

398

Ferrous Salt + Folic Acid 60 mg elemental iron +

400 microgram folic acid per tablet/ capsule/film

coated tablet

1,500 tablet 0.60 900.00

399Ferrous Salt Tablet, (equiv. to 60 mg elemental

iron)4,000 tablet 2.00 8,000.00

400 Folic Acid 5 mg tablet /capsule 100 capsule/

tablet 3.53 353.00

401 Iron Sucrose injection 20mg / 5 ml ampule 25 ampule 117.23 2,930.75

402 Multivitamins 15ml drops 55 bottle 26.50 1,457.50

403 Multivitamins 60ml syrup bottle 55 bottle 20.91 1,150.05

404 Multivitamins adults capsule 6,500 capsule 1.90 12,350.00

405 Phytomenadione 10mg, 1ml/ampule 1,000 ampule 19.65 19,650.00

406Vitamin B Complex (vitamin B1 B6 B12) 100 mg B1

+ 100 mg B6 + 1 mg B12 per mL,10 mL ampule (IV)500 ampule 19.80 9,900.00

407Vitamin B Complex (vitamin B1 B6 B12) 100 mg B1

+ 5 mg B6 + 50 microgram B12 per tablet/capsule250

tablet/

capsule 3.73 932.50

408 Zinc sulfate 27.5 mg/mL , 15 mL Oral Drops 50 bottle 38.00 1,900.00

TOTAL 16,974,737.79

GROUP 10 -VOLUME EXPANDER

409 Albumin, human 20% 50ml bottle 100 bottle 2,750.00 275,000.00

410 Albumin, human 25% 50ml bottle 500 bottle 2,654.00 1,327,000.00

411 Hydroxyethyl starch 6%, 500ml bag 400 bag 432.50 173,000.00

TOTAL 1,775,000.00

30,852,772.04 GRAND TOTAL

Republic of the Philippines Department of Health

‘AMANG’ RODRIGUEZ MEMORIAL MEDICAL CENTER Sumulong Highway, Sto. Niño, Marikina City, Philippines 1800

Email Address: [email protected] / Website: www.armmc.doh.gov.ph Tel. Nos. (+632) 941-5854 & (+632) 948-1263

“PHIC Accredited”

ARMMC INTERNAL GUIDELINES FOR THE PROCUREMENT OF GOODS DURING STATE OF CALAMITY,

IMPLEMENTATION OF COMMUNITY QUARANTINE OR SIMILAR RESTRICTIONS

1. PRE-PROCUREMENT CONFERENCE

Pre-procurement Conference will be through videoconferencing in Zoom or similar platform. It

shall be attended by the BAC, the Secretariat, TWG and End-users concerned, including those

who prepared the Bid /Purchase Request.

2. PRE-BID CONFERENCE

1. Pre-bid conference shall likewise be conducted through videoconferencing in

Zoom or similar platform.

2. It is open to prospective bidder, but attendance shall not be mandatory.

3. The prospective bidder must submit to the BAC Secretariat a letter of intent to

join the pre-bid video-conference not later than twenty-four (24) hours before the

scheduled time.

4. In case of bidders with corporate or juridical personality, they shall be required to

submit to the BAC Secretariat a Board Resolution indicating the name of its

authorized representative and to attach therein the latter’s proper identification

contact number and email address at least one day prior to the scheduled pre-bid

conference.

5. After proper verification, the BAC secretariat shall then send the link to the

prospective Bidder thru email as to where the virtual conference will be.

6. The minutes of the pre-bid video-conference shall be properly documented,

recorded and prepared.


http://www.armmc.doh.gov.ph/

7. Amendment on any provision of the Bidding Document shall be issued in writing

thru a Supplemental/Bid Bulletin at least seven (7) calendar days before the

deadline for the submission and receipt of bids.

3. SUBMISSION AND RECEIPT OF BIDS

1. The bidders shall submit their bids physically through their duly authorized

representative or courier using the forms specified in the Bidding Documents.

2. The deadline for the submission of bids shall be until 12:00 noon, one day prior to

the opening of bids. The BAC shall document receipt of bids and record in the

minutes of bid submission and opening, the bidder’s name, its representative or

courier, and the time the bid was submitted. Late bids shall not be accepted.

3. Unsealed or unmarked bid envelopes shall be rejected. However, bid envelopes

that are not properly sealed and marked, as required in the Bidding Documents,

shall be accepted, provided that the bidder or its duly authorized representative

shall acknowledge such condition of the bid as submitted.

4. A bidder may modify its bid, provided that this is done before the deadline of

submission and receipt of bids. Where a bidder modifies its bid, it shall not be

allowed to retrieve its original bid, but shall only be allowed to send another bid

equally sealed, properly identified, linked to its original bid and marked as a

“modification,” thereof, and stamped “received” by the BAC. Bid modifications

received after the applicable deadline shall not be considered and shall be

returned to the bidder unopened.

4. BID OPENING CONFERENCE

1. Bid Opening Conference shall also be through video-conferencing in Zoom or

similar platform.

2. Upon payment of bid documents, the BAC Secretariat shall inform the prospective

bidder or its duly authorized representative to submit proper identification, email

address, contact number and an authorization letter from the Company that is

being represented thru electronic mail one day prior to the scheduled opening of

bid conference.

3. After proper verification, the BAC Secretariat shall then send the link to the

prospective bidder thru email as to where the video-conference will be.

4. On Bid Opening, the BAC shall open the bids immediately after the deadline for

the submission and receipt of bids. The time, date, and place of the opening of

bids shall be specified in the Bidding Documents.

5. Actual bid opening will be done in combination of face-to-face and thru video-

conferencing. Only the members of the BAC will be on actual face to face during

bid opening. The observers and prospective bidders or their authorized

representative may attend the opening of bids via video-conferencing. The

proceedings of the pre-bid video-conference shall be recorded and minutes of the

meeting shall be prepared.

6. In case the bid cannot be opened as scheduled due to justifiable reasons, the BAC

shall take custody of the bids submitted and reschedule the opening of bids on

the next working day or at the soonest possible time through the issuance of a

Notice of Postponement to be posted in the PhilGEPS website and the website of

the Procuring Entity concerned.

7. The BAC shall ensure the integrity, security, and confidentiality of all submitted

bids. The abstract of bids as read and the minutes of the bid opening shall be made

available to the public upon written request.

Prepared by:

CLEOTILDE D. MALICSE MD, FPPS, DIH Chairperson, Bids and Awards Committee on Supplies, Drugs and Medicines 07/21/2020